@article{andersDetectingDifferentialUsage2012,
  title = {Detecting Differential Usage of Exons from {{RNA-seq}} Data},
  author = {Anders, Simon and Reyes, Alejandro and Huber, Wolfgang},
  year = 2012,
  month = jan,
  journal = {Genome Research},
  volume = {22},
  number = {10},
  pages = {2008--2017},
  publisher = {Cold Spring Harbor Lab},
  issn = {1088-9051, 1549-5469},
  doi = {10.1101/gr.133744.111},
  urldate = {2025-12-23},
  abstract = {RNA-seq is a powerful tool for the study of alternative splicing and other forms of alternative isoform expression. Understanding the regulation of these processes requires sensitive and specific detection of differential isoform abundance in comparisons between conditions, cell types, or tissues. We present DEXSeq, a statistical method to test for differential exon usage in RNA-seq data. DEXSeq uses generalized linear models and offers reliable control of false discoveries by taking biological variation into account. DEXSeq detects with high sensitivity genes, and in many cases exons, that are subject to differential exon usage. We demonstrate the versatility of DEXSeq by applying it to several data sets. The method facilitates the study of regulation and function of alternative exon usage on a genome-wide scale. An implementation of DEXSeq is available as an R/Bioconductor package.},
  langid = {english},
  pmid = {22722343},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/UNE6754J/Anders et al. - 2012 - Detecting differential usage of exons from RNA-seq data.pdf}
}

@article{bhadraAlternativeSplicingAging2020,
  title = {Alternative Splicing in Aging and Longevity},
  author = {Bhadra, Malini and Howell, Porsha and Dutta, Sneha and Heintz, Caroline and Mair, William B.},
  year = 2020,
  month = mar,
  journal = {Human Genetics},
  volume = {139},
  number = {3},
  pages = {357--369},
  issn = {1432-1203},
  doi = {10.1007/s00439-019-02094-6},
  urldate = {2025-12-26},
  abstract = {Alternative pre-mRNA splicing increases the complexity of the proteome that can be generated from the available genomic coding sequences. Dysregulation of the splicing process has been implicated in a vast repertoire of diseases. However, splicing has recently been linked to both the aging process itself and pro-longevity interventions. This review focuses on recent research towards defining RNA splicing as a new hallmark of aging. We highlight dysfunctional alternative splicing events that contribute to the aging phenotype across multiple species, along with recent efforts toward deciphering mechanistic roles for RNA splicing in the regulation of aging and longevity. Further, we discuss recent research demonstrating a direct requirement for specific splicing factors in pro-longevity interventions, and specifically how nutrient signaling pathways interface to splicing factor regulation and downstream splicing targets. Finally, we review the emerging potential of using splicing profiles as a predictor of biological age and life expectancy. Understanding the role of RNA splicing components and downstream targets altered in aging may provide opportunities to develop therapeutics and ultimately extend healthy lifespan in humans.},
  langid = {english}
}

@article{burnett-hartmanTreatmentPatternsSurvival2019,
  title = {Treatment Patterns and Survival Differ between Early-Onset and Late-Onset Colorectal Cancer Patients: The Patient Outcomes to Advance Learning Network},
  shorttitle = {Treatment Patterns and Survival Differ between Early-Onset and Late-Onset Colorectal Cancer Patients},
  author = {{Burnett-Hartman}, Andrea N. and Powers, J. David and Chubak, Jessica and Corley, Douglas A. and Ghai, Nirupa R. and McMullen, Carmit K. and Pawloski, Pamala A. and Sterrett, Andrew T. and Feigelson, Heather Spencer},
  year = 2019,
  month = jul,
  journal = {Cancer Causes \& Control},
  volume = {30},
  number = {7},
  pages = {747--755},
  issn = {1573-7225},
  doi = {10.1007/s10552-019-01181-3},
  urldate = {2025-12-23},
  abstract = {Our objective was to describe differences in treatment patterns and survival between early-onset ({$<$}\,50~years old) and late-onset colorectal cancer (CRC) patients in community-based health systems.},
  langid = {english},
  keywords = {Chemotherapy,Colorectal cancer,Early-onset,Survival,Treatment}
}

@article{caoIdentificationRNAStructures2024,
  title = {Identification of {{RNA}} Structures and Their Roles in {{RNA}} Functions},
  author = {Cao, Xinang and Zhang, Yueying and Ding, Yiliang and Wan, Yue},
  year = 2024,
  month = oct,
  journal = {Nature Reviews Molecular Cell Biology},
  volume = {25},
  number = {10},
  pages = {784--801},
  publisher = {Nature Publishing Group},
  issn = {1471-0080},
  doi = {10.1038/s41580-024-00748-6},
  urldate = {2025-08-26},
  abstract = {The development of high-throughput RNA structure profiling methods in the past decade has greatly facilitated our ability to map and characterize different aspects of RNA structures transcriptome-wide in cell populations, single cells and single molecules. The resulting high-resolution data have provided insights into the static and dynamic nature of RNA structures, revealing their complexity as they perform their respective functions in the cell. In this Review, we discuss recent technical advances in the determination of RNA structures, and the roles of RNA structures in RNA biogenesis and functions, including in transcription, processing, translation, degradation, localization and RNA structure-dependent condensates. We also discuss the current understanding of how RNA structures could guide drug design for treating genetic diseases and battling pathogenic viruses, and highlight existing challenges and future directions in RNA structure research.},
  copyright = {2024 Springer Nature Limited},
  langid = {english},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/3CK9MJCB/Cao et al. - 2024 - Identification of RNA structures and their roles i.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/RNA/SI_Identification of RNA structures and their roles in RNA functions.pdf}
}

@article{cornishGenomicLandscape20232024a,
  title = {The Genomic Landscape of 2,023 Colorectal Cancers},
  author = {Cornish, Alex J. and Gruber, Andreas J. and Kinnersley, Ben and Chubb, Daniel and Frangou, Anna and Caravagna, Giulio and Noyvert, Boris and Lakatos, Eszter and Wood, Henry M. and Thorn, Steve and Culliford, Richard and {Arnedo-Pac}, Claudia and Househam, Jacob and Cross, William and Sud, Amit and Law, Philip and Leathlobhair, Maire Ni and Hawari, Aliah and Woolley, Connor and Sherwood, Kitty and Feeley, Nathalie and G{\"u}l, G{\"u}ler and {Fernandez-Tajes}, Juan and Zapata, Luis and Alexandrov, Ludmil B. and Murugaesu, Nirupa and Sosinsky, Alona and Mitchell, Jonathan and {Lopez-Bigas}, Nuria and Quirke, Philip and Church, David N. and Tomlinson, Ian P. M. and Sottoriva, Andrea and Graham, Trevor A. and Wedge, David C. and Houlston, Richard S.},
  year = 2024,
  month = sep,
  journal = {Nature},
  volume = {633},
  number = {8028},
  pages = {127--136},
  publisher = {Nature Publishing Group},
  issn = {1476-4687},
  doi = {10.1038/s41586-024-07747-9},
  urldate = {2025-09-22},
  abstract = {Colorectal carcinoma (CRC) is a common cause of mortality1, but a comprehensive description of its genomic landscape is lacking2--9. Here we perform whole-genome sequencing of 2,023 CRC samples from participants in the UK 100,000 Genomes Project, thereby providing a highly detailed somatic mutational landscape of this cancer. Integrated analyses identify more than 250 putative CRC driver genes, many not previously implicated in CRC or other cancers, including several recurrent changes outside the coding genome. We extend the molecular pathways involved in CRC development, define four new common subgroups of microsatellite-stable CRC based on genomic features and show that these groups have independent prognostic associations. We also characterize several rare molecular CRC subgroups, some with potential clinical relevance, including cancers with both microsatellite and chromosomal instability. We demonstrate a spectrum of mutational profiles across the colorectum, which reflect aetiological differences. These include the role of Escherichia colipks+ colibactin in rectal cancers10 and the importance of the SBS93 signature11--13, which suggests that diet or smoking is a risk factor. Immune-escape driver mutations14 are near-ubiquitous in hypermutant tumours and occur in about half of microsatellite-stable CRCs, often in the form of HLA copy number changes. Many driver mutations are actionable, including those associated with rare subgroups (for example, BRCA1 and IDH1), highlighting the role of whole-genome sequencing in optimizing patient care.},
  copyright = {2024 The Author(s)},
  langid = {english},
  keywords = {Cancer genomics,Colorectal cancer,Evolutionary genetics,Genetics research,Next-generation sequencing},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/GACAHE74/Cornish et al. - 2024 - The genomic landscape of 2,023 colorectal cancers.pdf}
}

@article{danaeeBpRNALargescaleAutomated2018,
  title = {{{bpRNA}}: Large-Scale Automated Annotation and Analysis of {{RNA}} Secondary Structure},
  shorttitle = {{{bpRNA}}},
  author = {Danaee, Padideh and Rouches, Mason and Wiley, Michelle and Deng, Dezhong and Huang, Liang and Hendrix, David},
  year = 2018,
  month = jun,
  journal = {Nucleic Acids Research},
  volume = {46},
  number = {11},
  pages = {5381--5394},
  issn = {0305-1048},
  doi = {10.1093/nar/gky285},
  urldate = {2025-10-21},
  abstract = {While RNA secondary structure prediction from sequence data has made remarkable progress, there is a need for improved strategies for annotating the features of RNA secondary structures. Here, we present bpRNA, a novel annotation tool capable of parsing RNA structures, including complex pseudoknot-containing RNAs, to yield an objective, precise, compact, unambiguous, easily-interpretable description of all loops, stems, and pseudoknots, along with the positions, sequence, and flanking base pairs of each such structural feature. We also introduce several new informative representations of RNA structure types to improve structure visualization and interpretation. We have further used bpRNA to generate a web-accessible meta-database, `bpRNA-1m', of over 100 000 single-molecule, known secondary structures; this is both more fully and accurately annotated and over 20-times larger than existing databases. We use a subset of the database with highly similar ({$\geq$}90\% identical) sequences filtered out to report on statistical trends in sequence, flanking base pairs, and length. Both the bpRNA method and the bpRNA-1m database will be valuable resources both for specific analysis of individual RNA molecules and large-scale analyses such as are useful for updating RNA energy parameters for computational thermodynamic predictions, improving machine learning models for structure prediction, and for benchmarking structure-prediction algorithms.},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/QGJAASQL/Danaee et al. - 2018 - bpRNA large-scale automated annotation and analysis of RNA secondary structure.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/NRJIE23G/gky285.html}
}

@article{dongLMNB2PromotesProgression2021,
  title = {{{LMNB2}} Promotes the Progression of Colorectal Cancer by Silencing P21 Expression},
  author = {Dong, Chen-Hua and Jiang, Tao and Yin, Hang and Song, Hu and Zhang, Yi and Geng, Hao and Shi, Pei-Cong and Xu, Yi-Xin and Gao, Hong and Liu, Lian-Yu and Zhou, Lei and Zhang, Zhao-Hui and Song, Jun},
  year = 2021,
  month = mar,
  journal = {Cell Death \& Disease},
  volume = {12},
  number = {4},
  pages = {331},
  publisher = {Nature Publishing Group},
  issn = {2041-4889},
  doi = {10.1038/s41419-021-03602-1},
  urldate = {2026-01-03},
  abstract = {Colorectal cancer is the second common cause of death worldwide. Lamin B2 (LMNB2) is involved in chromatin remodeling and the rupture and reorganization of nuclear membrane during mitosis, which is necessary for eukaryotic cell proliferation. However, the role of LMNB2 in colorectal cancer (CRC) is poorly understood. This study explored the biological functions of LMNB2 in the progression of colorectal cancer and explored the possible molecular mechanisms. We found that LMNB2 was significantly upregulated in primary colorectal cancer tissues and cell lines, compared with paired non-cancerous tissues and normal colorectal epithelium. The high expression of LMNB2 in colorectal cancer tissues is significantly related to the clinicopathological characteristics of the patients and the shorter overall and disease-free cumulative survival. Functional analysis, including CCK8 cell proliferation test, EdU proliferation test, colony formation analysis, nude mouse xenograft, cell cycle, and apoptosis analysis showed that LMNB2 significantly promotes cell proliferation by promoting cell cycle progression in vivo and in vitro. In addition, gene set enrichment analysis, luciferase report analysis, and CHIP analysis showed that LMNB2 promotes cell proliferation by regulating the p21 promoter, whereas LMNB2 has no effect on cell apoptosis. In summary, these findings not only indicate that LMNB2 promotes the proliferation of colorectal cancer by regulating p21-mediated cell cycle progression, but also suggest the potential value of LMNB2 as a clinical prognostic marker and molecular therapy target.},
  copyright = {2021 The Author(s)},
  langid = {english},
  keywords = {Cancer,Diseases},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/557ERB6B/Dong et al. - 2021 - LMNB2 promotes the progression of colorectal cancer by silencing p21 expression.pdf}
}

@article{duIntegratedMultiomicsApproach2023,
  title = {Integrated Multi-Omics Approach to Distinct Molecular Characterization and Classification of Early-Onset Colorectal Cancer},
  author = {Du, Mulong and Gu, Dongying and Xin, Junyi and Peters, Ulrike and Song, Mingyang and Cai, Guoshuai and Li, Shuwei and Ben, Shuai and Meng, Yixuan and Chu, Haiyan and Chen, Lianmin and Wang, Qianghu and Zhu, Lingjun and Fu, Zan and Zhang, Zhengdong and Wang, Meilin},
  year = 2023,
  month = mar,
  journal = {Cell Reports Medicine},
  volume = {4},
  number = {3},
  pages = {100974},
  issn = {2666-3791},
  doi = {10.1016/j.xcrm.2023.100974},
  urldate = {2026-01-03},
  abstract = {Incidence of early-onset colorectal cancer (EOCRC), defined by a diagnosed age under 50 years, is increasing, but its heterogeneous etiologies that differ from general CRC remain undetermined. We initially characterize the genome, epigenome, transcriptome, and proteome of tumors from 79 patients in a Chinese CRC cohort. Data for an additional 126 EOCRC subjects are obtained from the International Cancer Genome Consortium Chinese cohort and The Cancer Genome Atlas European cohort. We observe that early-onset tumors have a high tumor mutation burden; increased DNA repair features by mutational signature 3 and multi-layer pathway enrichments; strong perturbations at effects of DNA methylation and~somatic copy-number alteration on gene expression; and upregulated immune infiltration as hot tumors underlying immunophenotypes. Notably, LMTK3 exhibits ancestral mutation disparity, potentially being a functional modulator and biomarker that drives molecular alterations in EOCRC development and immunotherapies. This integrative omics study provides valuable knowledge for precision oncology of CRC.},
  keywords = {early-onset colorectal cancer,immunophenotype,multi-omics},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/DAGJ5FIY/Du et al. - 2023 - Integrated multi-omics approach to distinct molecular characterization and classification of early-o.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/E8EPSYLI/S2666379123000800.html}
}

@article{duIntegratedMultiomicsApproach2023a,
  title = {Integrated Multi-Omics Approach to Distinct Molecular Characterization and Classification of Early-Onset Colorectal Cancer},
  author = {Du, Mulong and Gu, Dongying and Xin, Junyi and Peters, Ulrike and Song, Mingyang and Cai, Guoshuai and Li, Shuwei and Ben, Shuai and Meng, Yixuan and Chu, Haiyan and Chen, Lianmin and Wang, Qianghu and Zhu, Lingjun and Fu, Zan and Zhang, Zhengdong and Wang, Meilin},
  year = 2023,
  month = mar,
  journal = {Cell Reports Medicine},
  volume = {4},
  number = {3},
  pages = {100974},
  issn = {2666-3791},
  doi = {10.1016/j.xcrm.2023.100974},
  urldate = {2026-01-03},
  abstract = {Incidence of early-onset colorectal cancer (EOCRC), defined by a diagnosed age under 50 years, is increasing, but its heterogeneous etiologies that differ from general CRC remain undetermined. We initially characterize the genome, epigenome, transcriptome, and proteome of tumors from 79 patients in a Chinese CRC cohort. Data for an additional 126 EOCRC subjects are obtained from the International Cancer Genome Consortium Chinese cohort and The Cancer Genome Atlas European cohort. We observe that early-onset tumors have a high tumor mutation burden; increased DNA repair features by mutational signature 3 and multi-layer pathway enrichments; strong perturbations at effects of DNA methylation and~somatic copy-number alteration on gene expression; and upregulated immune infiltration as hot tumors underlying immunophenotypes. Notably, LMTK3 exhibits ancestral mutation disparity, potentially being a functional modulator and biomarker that drives molecular alterations in EOCRC development and immunotherapies. This integrative omics study provides valuable knowledge for precision oncology of CRC.},
  keywords = {early-onset colorectal cancer,immunophenotype,multi-omics},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/FSQIU5Q9/Du et al. - 2023 - Integrated multi-omics approach to distinct molecular characterization and classification of early-o.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/RT2ZY7HJ/S2666379123000800.html}
}

@article{ewelsNfcoreFrameworkCommunitycurated2020,
  title = {The Nf-Core Framework for Community-Curated Bioinformatics Pipelines},
  author = {Ewels, Philip A. and Peltzer, Alexander and Fillinger, Sven and Patel, Harshil and Alneberg, Johannes and Wilm, Andreas and Garcia, Maxime Ulysse and Di Tommaso, Paolo and Nahnsen, Sven},
  year = 2020,
  month = mar,
  journal = {Nature Biotechnology},
  volume = {38},
  number = {3},
  pages = {276--278},
  publisher = {Nature Publishing Group},
  issn = {1546-1696},
  doi = {10.1038/s41587-020-0439-x},
  urldate = {2025-12-15},
  copyright = {2020 The Author(s), under exclusive licence to Springer Nature America, Inc.},
  langid = {english},
  keywords = {Computational biology and bioinformatics,Scientific community},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/5PQ9SS8K/Ewels et al. - 2020 - The nf-core framework for community-curated bioinformatics pipelines.pdf}
}

@article{gardnerDistinctInnateImmune2021,
  title = {A {{Distinct Innate Immune Signature}} of {{Early Onset Colorectal Cancer}}},
  author = {Gardner, Ivy H and Siddharthan, Ragavan and Watson, Katherine and Dewey, Elizabeth and Ruhl, Rebecca and Khou, Sokchea and Guan, Xiangnan and Xia, Zheng and Tsikitis, V Liana and Anand, Sudarshan},
  year = 2021,
  month = jun,
  journal = {ImmunoHorizons},
  volume = {5},
  number = {6},
  pages = {489--499},
  issn = {2573-7732},
  doi = {10.4049/immunohorizons.2000092},
  urldate = {2026-01-03},
  abstract = {Despite a decrease in the prevalence of colorectal cancer (CRC) over the last 40 y, the prevalence of CRC in people under 50 y old is increasing around the globe. Early onset ({$\leq$}50 y old) and late onset ({$\geq$}65 y old) CRC appear to have differences in their clinicopathological and genetic features, but it is unclear if there are differences in the tumor microenvironment. We hypothesized that the immune microenvironment of early onset CRC is distinct from late onset CRC and promotes tumor progression. We used NanoString immune profiling to analyze mRNA expression of immune genes in formalin-fixed paraffin-embedded surgical specimens from patients with early (n = 40) and late onset (n = 39) CRC. We found three genes, SAA1, C7, and CFD, have increased expression in early onset CRC and distinct immune signatures based on the tumor location. After adjusting for clinicopathological features, increased expression of CFD and SAA1 were associated with worse progression-free survival, and increased expression of C7 was associated with worse overall survival. We also performed gain-of-function experiments with CFD and SAA1 in s.c. tumor models and found that CFD is associated with higher tumor volumes, impacted several immune genes, and impacted three genes in mice that were also found to be differentially expressed in early onset CRC (EGR1, PSMB9, and CXCL9). Our data demonstrate that the immune microenvironment, characterized by a distinct innate immune response signature in early onset CRC, is unique, location dependent, and might contribute to worse outcomes.},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/FBPTAMT3/Gardner et al. - 2021 - A Distinct Innate Immune Signature of Early Onset Colorectal Cancer.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/HL7SMCZX/immunohorizons.html}
}

@article{garrettEarlyonsetColorectalCancer2022,
  title = {Early-Onset Colorectal Cancer: Why It Should Be High on Our List of Differentials},
  shorttitle = {Early-Onset Colorectal Cancer},
  author = {Garrett, Celine and Steffens, Daniel and Solomon, Michael and Koh, Cherry},
  year = 2022,
  journal = {ANZ Journal of Surgery},
  volume = {92},
  number = {7-8},
  pages = {1638--1643},
  issn = {1445-2197},
  doi = {10.1111/ans.17698},
  urldate = {2026-01-03},
  abstract = {Background Early-onset colorectal cancer (EOCRC) ({$<$}50 years) incidence has increased in Australia and worldwide. However, the diagnosis of EOCRC is often delayed. Recent research has discovered some differences from later-onset colorectal cancer (LOCRC) ({$>$}50 years). An awareness of the unique features of EOCRC is crucial to reduce time from symptom onset to diagnosis. Methods A literature search was conducted on electronic databases (MEDLINE, EMBASE and Cochrane Library) using the search terms ``early onset colorectal cancer'' or ``young onset colorectal cancer.'' Results The American Cancer Society has reduced the colorectal cancer screening initiation age to 45 for average-risk adults whilst screening programmes in the United Kingdom and Australia remain unchanged with initiation at 60 and 50, respectively. Exposures resulting in dysbiosis (obesity, westernised diet, alcohol, antibiotic and sugar-sweetened beverage consumption) have been linked with increased EOCRC risk. EOCRC is often left-sided presenting with rectal bleeding, altered bowel habit and constitutional symptoms. EOCRC is more commonly sporadic than hereditary, harbouring different genetic mutations than LOCRC. Comparative survival outcomes of EOCRC and LOCRC are conflicting with studies suggesting either better or poorer survival. Young patients better tolerate treatment-related toxicities, which may account for their improved survival despite comparatively advanced stages and poorer histopathological features at diagnosis. Conclusion Current EOCRC literature is limited by American-focused datasets and heterogenous EOCRC definitions and study designs (the greatest strength of evidence exists for EOCRC risk factor studies comprised of large retrospective cohorts). There is minimal research into the quality of life and surgical outcomes of EOCRC patients, and this area warrants further investigation.},
  copyright = {\copyright{} 2022 The Authors. ANZ Journal of Surgery published by John Wiley \& Sons Australia, Ltd on behalf of Royal Australasian College of Surgeons.},
  langid = {english},
  keywords = {early-onset colorectal cancer,molecular profile,presentation,risk factors,screening},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/ENKTLY6J/Garrett et al. - 2022 - Early-onset colorectal cancer why it should be high on our list of differentials.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/RR4HHGWS/ans.html}
}

@article{gorrono-etxebarriaWnt11PotentialPrognostic2019,
  title = {Wnt-11 as a {{Potential Prognostic Biomarker}} and {{Therapeutic Target}} in {{Colorectal Cancer}}},
  author = {{Gorro{\~n}o-Etxebarria}, Irantzu and Aguirre, Urko and Sanchez, Saray and Gonz{\'a}lez, Nerea and Escobar, Antonio and Zabalza, Ignacio and Quintana, Jos{\'e} Maria and dM Vivanco, Maria and Waxman, Jonathan and Kypta, Robert M.},
  year = 2019,
  month = jun,
  journal = {Cancers},
  volume = {11},
  number = {7},
  pages = {908},
  issn = {2072-6694},
  doi = {10.3390/cancers11070908},
  abstract = {The expression of the secreted factor Wnt-11 is elevated in several types of cancer, including colorectal cancer, where it promotes cancer cell migration and invasion. Analysis of colorectal cancer gene expression databases associated WNT11 mRNA expression with increased likelihood of metastasis in a subset of patients. WNT11 expression was correlated with the expression of the Wnt receptors FZD6, RYK, and PTK7, and the combined expression of WNT11, FZD6 and RYK or PTK7 was associated with an increased risk of 5-year mortality rates. Immunohistochemical analysis of Wnt-11 in a cohort of 357 colorectal cancer patients found significantly higher Wnt-11 levels in tumors, compared with benign tissue. Elevated Wnt-11 levels occurred more frequently in rectal tumors than in colonic tumors and in tumors from women than men. In univariate analysis, increased Wnt-11 expression was also associated with tumor invasion and increased 5-year mortality. High Wnt-11 levels were not associated with high levels of nuclear {$\beta$}-catenin, suggesting Wnt-11 is not simply an indicator for activation of {$\beta$}-catenin-dependent signaling. Expression of Wnt-11 in colorectal cancer cell lines expressing low endogenous Wnt-11 inhibited {$\beta$}-catenin/Tcf activity and increased ATF2-dependent transcriptional activity. WNT11 gene silencing and antibody-mediated inhibition of Wnt-11 in colorectal cancer cell lines expressing high Wnt-11 reduced their capacity for invasion. Together, these observations suggest that Wnt-11 could be a potential target for the treatment of patients with invasive colorectal cancer.},
  langid = {english},
  pmcid = {PMC6679153},
  pmid = {31261741},
  keywords = {colorectal cancer,frizzled,Wnt signaling,Wnt-11},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/Z4XNNR46/Gorro√±o-Etxebarria et al. - 2019 - Wnt-11 as a Potential Prognostic Biomarker and Therapeutic Target in Colorectal Cancer.pdf}
}

@article{hallRNASplicingKey2022,
  title = {{{RNA}} Splicing Is a Key Mediator of Tumour Cell Plasticity and a Therapeutic Vulnerability in Colorectal Cancer},
  author = {Hall, Adam E. and Pohl, Sebastian {\"O}ther-Gee and Cammareri, Patrizia and Aitken, Stuart and Younger, Nicholas T. and Raponi, Michela and Billard, Caroline V. and Carrancio, Alfonso Bolado and Bastem, Aslihan and Freile, Paz and Haward, Fiona and Adams, Ian R. and Caceres, Javier F. and Preyzner, Paula and {von Kriegsheim}, Alex and Dunlop, Malcolm G. and Din, Farhat V. and Myant, Kevin B.},
  year = 2022,
  month = may,
  journal = {Nature Communications},
  volume = {13},
  number = {1},
  pages = {2791},
  publisher = {Nature Publishing Group},
  issn = {2041-1723},
  doi = {10.1038/s41467-022-30489-z},
  urldate = {2025-12-26},
  abstract = {Tumour cell plasticity is a major barrier to the efficacy of targeted cancer therapies but the mechanisms that mediate it are poorly understood. Here, we identify dysregulated RNA splicing as a key driver of tumour cell dedifferentiation in colorectal cancer (CRC). We find that Apc-deficient CRC cells have dysregulated RNA splicing machinery and exhibit global rewiring of RNA splicing. We show that the splicing factor SRSF1 controls the plasticity of tumour cells by controlling Kras splicing and is required for CRC invasion in a mouse model of carcinogenesis. SRSF1 expression maintains stemness in human CRC organoids and correlates with cancer stem cell marker expression in human tumours. Crucially, partial genetic downregulation of Srsf1 does not detrimentally affect normal tissue homeostasis, demonstrating that tumour cell plasticity can be differentially targeted. Thus, our findings link dysregulation of the RNA splicing machinery and control of tumour cell plasticity.},
  copyright = {2022 The Author(s)},
  langid = {english},
  keywords = {Cancer models,Colon cancer,Oncogenes},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/AQ66YYG2/Hall et al. - 2022 - RNA splicing is a key mediator of tumour cell plasticity and a therapeutic vulnerability in colorect.pdf}
}

@article{haReducedExpressionAlanyl2023,
  title = {Reduced Expression of Alanyl Aminopeptidase Is a Robust Biomarker of Non-Familial Adenomatous Polyposis and Non-Hereditary Nonpolyposis Colorectal Cancer Syndrome Early-Onset Colorectal Cancer},
  author = {Ha, Ye Jin and Shin, Yun Jae and Tak, Ka Hee and Park, Jong Lyul and Kim, Jeong Hwan and Lee, Jong Lyul and Yoon, Yong Sik and Kim, Chan Wook and Kim, Seon Young and Kim, Jin Cheon},
  year = 2023,
  journal = {Cancer Medicine},
  volume = {12},
  number = {8},
  pages = {10091--10104},
  issn = {2045-7634},
  doi = {10.1002/cam4.5675},
  urldate = {2025-12-26},
  abstract = {Background Early-onset colorectal cancer (EOCRC) has been increasing in incidence worldwide but its genomic pathogenesis is mostly undetermined. This study aimed to identify robust EOCRC-specific gene expression patterns in non-familial adenomatous polyposis (FAP) and non-hereditary nonpolyposis colorectal cancer syndrome (HNPCC) EOCRC. Method We first performed gene expression profiling analysis using RNA sequencing of discovery cohort comprised of 49 EOCRC (age {$<$}50) and 50 late-onset colorectal cancer (LOCRC) (age {$>$}70) specimens. To obtain robust gene expression data from this analysis, we validated differentially expressed genes (DEGs) through TCGA cohort (EOCRC:59 samples, LOCRC:229 samples) and our validation cohort (EOCRC:72 samples, LOCRC:43 samples) using real-time RT-PCR. After the validation of DEGs, we validated the selected gene at protein levels using Western blotting. To identify whether genomic methylation regulates the expression of a particular gene, we selected methylation sites using The Cancer Genome Atlas (TCGA) datasets and validated them by pyrosequencing in our validation cohort. Results The EOCRC patients included in this study had significantly more prominent family history of cancer than the LOCRC patients (23 [46.9\%] vs. 13 [26\%], p = 0.050). Alanyl aminopeptidase (ANPEP) was significantly downregulated in the EOCRC tissues (FC = 1.78, p = 0.0007) and was also commonly downregulated in the TCGA cohort (FC = -1.08, p = 0.0021). Moreover, the ANPEP mRNA and protein expression levels were significantly downregulated in the EOCRC tissues of our validation cohort (p = 0.037 and 0.027). In comparisons of the normal and tumor tissues in public datasets, the ANPEP level was significantly lower in the tumor tissue in the TCGA dataset (p {$<$} 2.2 \texttimes{} 10-16) and GSE196006 dataset (p = 0.0005). Furthermore, the ANPEP expression level did not show a decreasing tendency at a young age in the normal colon tissue of the GTEx dataset. Lastly, the hypermethylation of cg26222247 in ANPEP was identified to be weakly associated with reduced ANPEP expression in our EOCRC cohort. Conclusion The reduced expression of ANPEP was identified as a novel biomarker of non-FAP and non-HNPCC EOCRC.},
  copyright = {\copyright{} 2023 The Authors. Cancer Medicine published by John Wiley \& Sons Ltd.},
  langid = {english},
  keywords = {ANPEP,biomarker,early-onset colorectal cancer (EOCRC),late-onset colorectal cancer (LOCRC)},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/ALRHYGSZ/Ha et al. - 2023 - Reduced expression of alanyl aminopeptidase is a robust biomarker of non-familial adenomatous polypo.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/296JH2UZ/cam4.html}
}

@article{hofackerSecondaryStructurePrediction2002,
  title = {Secondary {{Structure Prediction}} for {{Aligned RNA Sequences}}},
  author = {Hofacker, Ivo L. and Fekete, Martin and Stadler, Peter F.},
  year = 2002,
  month = jun,
  journal = {Journal of Molecular Biology},
  volume = {319},
  number = {5},
  pages = {1059--1066},
  issn = {0022-2836},
  doi = {10.1016/S0022-2836(02)00308-X},
  urldate = {2025-12-26},
  abstract = {Most functional RNA molecules have characteristic secondary structures that are highly conserved in evolution. Here we present a method for computing the consensus structure of a set aligned RNA sequences taking into account both thermodynamic stability and sequence covariation. Comparison with phylogenetic structures of rRNAs shows that a reliability of prediction of more than 80\% is achieved for only five related sequences. As an application we show that the Early Noduline mRNA contains significant secondary structure that is supported by sequence covariation.},
  keywords = {compensatory mutations,conserved substructures,RNA secondary structure prediction},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/NQHJNY63/S002228360200308X.html}
}

@article{huangPeptideEncodedPutative2017,
  title = {A {{Peptide Encoded}} by a {{Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth}}},
  author = {Huang, Jin-Zhou and Chen, Min and Chen, De and Gao, Xing-Cheng and Zhu, Song and Huang, Hongyang and Hu, Min and Zhu, Huifang and Yan, Guang-Rong},
  year = 2017,
  month = oct,
  journal = {Molecular Cell},
  volume = {68},
  number = {1},
  pages = {171-184.e6},
  publisher = {Elsevier},
  issn = {1097-2765},
  doi = {10.1016/j.molcel.2017.09.015},
  urldate = {2026-01-03},
  abstract = {{$<$}h2{$>$}Summary{$<$}/h2{$><$}p{$>$}A substantial fraction of eukaryotic transcripts are considered long non-coding RNAs (lncRNAs), which regulate various hallmarks of cancer. Here, we discovered that the lncRNA \emph{HOXB-AS3} encodes a conserved 53-aa peptide. The HOXB-AS3 peptide, not lncRNA, suppresses colon cancer (CRC) growth. Mechanistically, the HOXB-AS3 peptide competitively binds to the ariginine residues in RGG motif of hnRNP A1 and antagonizes the hnRNP A1-mediated regulation of pyruvate kinase M (PKM) splicing by blocking the binding of the ariginine residues in RGG motif of hnRNP A1 to the sequences flanking \emph{PKM} exon 9, ensuring the formation of lower PKM2 and suppressing glucose metabolism reprogramming. CRC patients with low levels of HOXB-AS3 peptide have poorer prognoses. Our study indicates that the loss of HOXB-AS3 peptide is a critical oncogenic event in CRC metabolic reprogramming. Our findings uncover a complex regulatory mechanism of cancer metabolism reprogramming orchestrated by a peptide encoded by an lncRNA.{$<$}/p{$>$}},
  langid = {english},
  pmid = {28985503}
}

@article{innesGeneExpressionAlternative2024,
  title = {Gene Expression and Alternative Splicing Contribute to Adaptive Divergence of Ecotypes},
  author = {Innes, Peter A. and Goebl, April M. and Smith, Chris C. R. and Rosenberger, Kaylee and Kane, Nolan C.},
  year = 2024,
  month = mar,
  journal = {Heredity},
  volume = {132},
  number = {3},
  pages = {120--132},
  publisher = {Nature Publishing Group},
  issn = {1365-2540},
  doi = {10.1038/s41437-023-00665-y},
  urldate = {2026-01-03},
  abstract = {Regulation of gene expression is a critical link between genotype and phenotype explaining substantial heritable variation within species. However, we are only beginning to understand the ways that specific gene regulatory mechanisms contribute to adaptive divergence of populations. In plants, the post-transcriptional regulatory mechanism of alternative splicing (AS) plays an important role in both development and abiotic stress response, making it a compelling potential target of natural selection. AS allows organisms to generate multiple different transcripts/proteins from a single gene and thus may provide a source of evolutionary novelty. Here, we examine whether variation in alternative splicing and gene expression levels might contribute to adaptation and incipient speciation of dune-adapted prairie sunflowers in Great Sand Dunes National Park, Colorado, USA. We conducted a common garden experiment to assess transcriptomic variation among ecotypes and analyzed differential expression, differential splicing, and gene coexpression. We show that individual genes are strongly differentiated for both transcript level and alternative isoform proportions, even when grown in a common environment, and that gene coexpression networks are disrupted between ecotypes. Furthermore, we examined how genome-wide patterns of sequence divergence correspond to divergence in transcript levels and isoform proportions and find evidence for both cis and trans-regulation. Together, our results emphasize that alternative splicing has been an underappreciated mechanism providing source material for natural selection at short evolutionary time scales.},
  copyright = {2023 The Author(s), under exclusive licence to The Genetics Society},
  langid = {english},
  keywords = {Evolutionary genetics,Gene expression,Gene regulation,Genetic variation,RNA splicing},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/3RD6HY5Z/Innes et al. - 2024 - Gene expression and alternative splicing contribute to adaptive divergence of ecotypes.pdf}
}

@article{jiangWNT11PromotesImmune2025,
  title = {{{WNT11 Promotes}} Immune Evasion and Resistance to {{Anti-PD-1}} Therapy in Liver Metastasis},
  author = {Jiang, Weiliang and Guan, Bingjie and Sun, Hongcheng and Mi, Yushuai and Cai, Sanjun and Wan, Rong and Li, Xinxiang and Lian, Peng and Li, Dawei and Zhao, Senlin},
  year = 2025,
  month = feb,
  journal = {Nature Communications},
  volume = {16},
  number = {1},
  pages = {1429},
  publisher = {Nature Publishing Group},
  issn = {2041-1723},
  doi = {10.1038/s41467-025-56714-z},
  urldate = {2026-01-03},
  abstract = {Liver metastasis (LM) poses a significant challenge in cancer treatment, with limited available therapeutic options and poor prognosis. Understanding the dynamics of tumor microenvironment (TME) and immune interactions is crucial for developing effective treatments. We find that WNT11 promoted CD8+ T-cell exclusion and suppression, which was correlated with poor prognosis in LM. Mechanistically, WNT11-overexpressing tumor cells directly reduce CD8+ T-cell recruitment and activity by decreasing CXCL10 and CCL4 expression through CAMKII-mediated {$\beta$}-catenin/AFF3 downregulation. WNT11-overexpressing tumor cells promote immunosuppressive macrophage polarization by inducing IL17D expression via the CAMKII/NF-{$\kappa$}B pathway, which result in CD8+ T-cell suppression. Moreover, CAMKII inhibition increases the efficacy of anti-PD-1 therapy in mouse model of LM. Serum expression of WNT11 is identified as a potential minimally invasive biomarker in the management of colorectal cancer-LM with immunotherapy. Our findings highlight WNT11/CAMKII axis as a critical regulator of the TME and a promising target for immunotherapy in patients with LM.},
  copyright = {2025 The Author(s)},
  langid = {english},
  keywords = {Gastrointestinal cancer,Immune evasion},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/J2P6X64V/Jiang et al. - 2025 - WNT11 Promotes immune evasion and resistance to Anti-PD-1 therapy in liver metastasis.pdf}
}

@article{jonesLongreadRNASequencing2024,
  title = {Long-Read {{RNA}} Sequencing Identifies Region- and Sex-Specific {{C57BL}}/{{6J}} Mouse Brain {{mRNA}} Isoform Expression and Usage},
  author = {Jones, Emma F. and Howton, Timothy C. and Flanary, Victoria L. and Clark, Amanda D. and Lasseigne, Brittany N.},
  year = 2024,
  month = jun,
  journal = {Molecular Brain},
  volume = {17},
  number = {1},
  pages = {40},
  issn = {1756-6606},
  doi = {10.1186/s13041-024-01112-7},
  urldate = {2026-01-01},
  abstract = {Alternative splicing (AS) contributes to the biological heterogeneity between species, sexes, tissues, and cell types. Many diseases are either caused by alterations in AS or by alterations to AS. Therefore, measuring AS accurately and efficiently is critical for assessing molecular phenotypes, including those associated with disease. Long-read sequencing enables more accurate quantification of differentially spliced isoform expression than short-read sequencing approaches, and third-generation platforms facilitate high-throughput experiments. To assess differences in AS across the cerebellum, cortex, hippocampus, and striatum by sex, we generated and analyzed Oxford Nanopore Technologies (ONT) long-read RNA sequencing (lrRNA-Seq) C57BL/6J mouse brain cDNA libraries. From {$>$}\,85~million reads that passed quality control metrics, we calculated differential gene expression (DGE), differential transcript expression (DTE), and differential transcript usage (DTU) across brain regions and by sex. We found significant DGE, DTE, and DTU across brain regions and that the cerebellum had the most differences compared to the other three regions. Additionally, we found region-specific differential splicing between sexes, with the most sex differences in DTU in the cortex and no DTU in the hippocampus. We also report on two distinct patterns of sex DTU we observed, sex-divergent and sex-specific, that could potentially help explain sex differences in the prevalence and prognosis of various neurological and psychiatric disorders in future studies. Finally, we built a Shiny web application for researchers to explore the data further. Our study provides a resource for the community; it underscores the importance of AS in biological heterogeneity and the utility of long-read sequencing to better understand AS in the brain.},
  langid = {english},
  keywords = {Brain,Isoform usage,Long-read RNA sequencing,Sex,Transcript usage},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/VX9WMTKW/Jones et al. - 2024 - Long-read RNA sequencing identifies region- and sex-specific C57BL6J mouse brain mRNA isoform expre.pdf}
}

@article{kerpedjievFornaForcedirectedRNA2015,
  title = {Forna (Force-Directed {{RNA}}): {{Simple}} and Effective Online {{RNA}} Secondary Structure Diagrams},
  shorttitle = {Forna (Force-Directed {{RNA}})},
  author = {Kerpedjiev, Peter and Hammer, Stefan and Hofacker, Ivo L.},
  year = 2015,
  month = oct,
  journal = {Bioinformatics},
  volume = {31},
  number = {20},
  pages = {3377--3379},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/btv372},
  urldate = {2025-10-13},
  abstract = {Motivation: The secondary structure of RNA is integral to the variety of functions it carries out in the cell and its depiction allows researchers to develop hypotheses about which nucleotides and base pairs are functionally relevant. Current approaches to visualizing secondary structure provide an adequate platform for the conversion of static text-based representations to 2D images, but are limited in their offer of interactivity as well as their ability to display larger structures, multiple structures and pseudoknotted structures.Results: In this article, we present forna, a web-based tool for displaying RNA secondary structure which allows users to easily convert sequences and secondary structures to clean, concise and customizable visualizations. It supports, among other features, the simultaneous visualization of multiple structures, the display of pseudoknotted structures, the interactive editing of the displayed structures, and the automatic generation of secondary structure diagrams from PDB files. It requires no software installation apart from a modern web browser.Availability and implementation: The web interface of forna is available at http://rna.tbi.univie.ac.at/forna while the source code is available on github at www.github.com/pkerpedjiev/forna.Contact: ~pkerp@tbi.univie.ac.atSupplementary information: ~Supplementary data are available at Bioinformatics online.},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/AJKJKF3N/Kerpedjiev et al. - 2015 - Forna (force-directed RNA) Simple and effective online RNA secondary structure diagrams.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/6UNNQTNC/btv372.html}
}

@article{khanIsoformSwitchingLeads2023,
  title = {Isoform Switching Leads to Downregulation of Cytokine Producing Genes in Estrogen Receptor Positive Breast Cancer},
  author = {Khan, Mohammad Shahbaz and Hanif, Waqar and Alsakhen, Nada and Jabbar, Basit and Shamkh, Israa M. and Alsaiari, Ahad Amer and Almehmadi, Mazen and Alghamdi, Saad and Shakoori, Afnan and Al Farraj, Dunia A. and Almutairi, Saeedah Musaed and Hussein Issa Mohammed, Yasser and Abouzied, Amr S. and Rehman, Aziz-Ur and Huwaimel, Bader},
  year = 2023,
  month = oct,
  journal = {Frontiers in Genetics},
  volume = {14},
  publisher = {Frontiers},
  issn = {1664-8021},
  doi = {10.3389/fgene.2023.1230998},
  urldate = {2026-01-01},
  abstract = {Estrogen receptor breast cancer is the most prevalent type of breast cancer, characterized by expression of estrogen receptors. It is the most common cancer among women with an incidence rate of 2.26 million cases worldwide. The aim of this study was to identify differentially expressed genes and isoform switching between estrogen receptor positive and triple negative breast cancer samples. For this study, the data was collected from ArrayExpress, followed by preprocessing and subsequent mapping from HISAT2. Read quantification was performed by StringTie and then R package ballgown was used to perform differential expression analysis. Functional enrichment analysis was conducted using EnrichR and then immune genes were shortlisted based on the ScType marker database. Furthermore isoform switch analysis was performed using isoformSwitchAnalyzeR package. A total of 9,771 differentially expressed genes were identified and among them 86 were upregulated and 117 were downregulated. Six genes were identified to be mainly associated with estrogen receptor positive breast cancer while a novel set of ten genes were found which have not been reported in estrogen receptor positive breast cancer previously. Moreover, alternative splicing and subsequent isoform usage in the immune system related genes were determined. This study identifies that differential usage of isoforms in the immune system related genes in cancer cells that suggest immunosuppression due to dysregulation of CXCR chemokine receptor binding, iron ion binding and cytokine activity.},
  langid = {english},
  keywords = {breast cancer,CXCR chemokine receptor,cytokine,differential expression,estrogen receptor,Functional enrichment,Immunosuppression,Isoform Switching},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/LKWFR4HQ/Khan et al. - 2023 - Isoform switching leads to downregulation of cytokine producing genes in estrogen receptor positive.pdf}
}

@article{kongIntegratedMetagenomicMetabolomic2023,
  title = {Integrated Metagenomic and Metabolomic Analysis Reveals Distinct Gut-Microbiome-Derived Phenotypes in Early-Onset Colorectal Cancer},
  author = {Kong, Cheng and Liang, Lei and Liu, Guang and Du, Lutao and Yang, Yongzhi and Liu, Jianqiang and Shi, Debing and Li, Xinxiang and Ma, Yanlei},
  year = 2023,
  month = jun,
  journal = {Gut},
  volume = {72},
  number = {6},
  pages = {1129--1142},
  publisher = {BMJ Publishing Group},
  issn = {0017-5749, 1468-3288},
  doi = {10.1136/gutjnl-2022-327156},
  urldate = {2026-01-03},
  abstract = {Objective The incidence of early-onset colorectal cancer (EO-CRC) is steadily increasing. Here, we aimed to characterise the interactions between gut microbiome, metabolites and microbial enzymes in EO-CRC patients and evaluate their potential as non-invasive biomarkers for EO-CRC. Design We performed metagenomic and metabolomic analyses, identified multiomics markers and constructed CRC classifiers for the discovery cohort with 130 late-onset CRC (LO-CRC), 114 EO-CRC subjects and age-matched healthy controls (97 LO-Control and 100 EO-Control). An independent cohort of 38 LO-CRC, 24 EO-CRC, 22 LO-Controls and 24 EO-Controls was analysed to validate the results. Results Compared with controls, reduced alpha-diversity was apparent in both, LO-CRC and EO-CRC subjects. Although common variations existed, integrative analyses identified distinct microbiome--metabolome associations in LO-CRC and EO-CRC. Fusobacterium nucleatum enrichment and short-chain fatty acid depletion, including reduced microbial GABA biosynthesis and a shift in acetate/acetaldehyde metabolism towards acetyl-CoA production characterises LO-CRC. In comparison, multiomics signatures of EO-CRC tended to be associated with enriched Flavonifractor plauti and increased tryptophan, bile acid and choline metabolism. Notably, elevated red meat intake-related species, choline metabolites and KEGG orthology (KO) pldB and cbh gene axis may be potential tumour stimulators in EO-CRC. The predictive model based on metagenomic, metabolomic and KO gene markers achieved a powerful classification performance for distinguishing EO-CRC from controls. Conclusion Our large-sample multiomics data suggest that altered microbiome--metabolome interplay helps explain the pathogenesis of EO-CRC and LO-CRC. The potential of microbiome-derived biomarkers as promising non-invasive tools could be used for the accurate detection and distinction of individuals with EO-CRC.},
  chapter = {Gut microbiota},
  copyright = {\copyright{} Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.},
  langid = {english},
  pmid = {35953094},
  keywords = {COLORECTAL CANCER}
}

@article{leinonenSequenceReadArchive2011,
  title = {The {{Sequence Read Archive}}},
  author = {Leinonen, Rasko and Sugawara, Hideaki and Shumway, Martin and {on behalf of the International Nucleotide Sequence Database Collaboration}},
  year = 2011,
  month = jan,
  journal = {Nucleic Acids Research},
  volume = {39},
  number = {suppl\_1},
  pages = {D19-D21},
  issn = {0305-1048},
  doi = {10.1093/nar/gkq1019},
  urldate = {2025-12-23},
  abstract = {The combination of significantly lower cost and increased speed of sequencing has resulted in an explosive growth of data submitted into the primary next-generation sequence data archive, the Sequence Read Archive (SRA). The preservation of experimental data is an important part of the scientific record, and increasing numbers of journals and funding agencies require that next-generation sequence data are deposited into the SRA. The SRA was established as a public repository for the next-generation sequence data and is operated by the International Nucleotide Sequence Database Collaboration (INSDC). INSDC partners include the National Center for Biotechnology Information (NCBI), the European Bioinformatics Institute (EBI) and the DNA Data Bank of Japan (DDBJ). The SRA is accessible at http://www.ncbi.nlm.nih.gov/Traces/sra from NCBI, at http://www.ebi.ac.uk/ena from EBI and at http://trace.ddbj.nig.ac.jp from DDBJ. In this article, we present the content and structure of the SRA, detail our support for sequencing platforms and provide recommended data submission levels and formats. We also briefly outline our response to the challenge of data growth.},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/2P64636W/Leinonen et al. - 2011 - The Sequence Read Archive.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/FTHEP6VH/gkq1019.html}
}

@misc{liInitioRNAStructure2025,
  title = {Ab Initio {{RNA}} Structure Prediction with Composite Language Model and Denoised End-to-End Learning},
  author = {Li, Yang and Feng, Chenjie and Zhang, Xi and Zhang, Yang},
  year = 2025,
  month = mar,
  primaryclass = {New Results},
  pages = {2025.03.05.641632},
  publisher = {bioRxiv},
  doi = {10.1101/2025.03.05.641632},
  urldate = {2025-10-21},
  abstract = {RNA structures are essential for understanding their biological functions and developing RNA-targeted therapeutics. However, accurate RNA structure prediction from sequence remains a crucial challenge. We introduce DRfold2, a deep learning framework that integrates a novel pre-trained RNA Composite Language Model (RCLM) with a denoising structure module for end-to-end RNA structure prediction. DRfold2 achieves superior performance in both global topology and secondary structure predictions over other state-of-the-art approaches across multiple benchmark tests. Detailed analyses reveal that the improvements primarily stem from the RCLM's ability to capture co-evolutionary pattern and the effective denoising process, leading to a more than 100\% increase in contact prediction precision compared to existing methods. Furthermore, DRfold2 demonstrates high complementarity with AlphaFold3, achieving statistically significant accuracy gains when integrated into our optimization framework. By uniquely combining composite language modeling, denoise-based end-to-end learning, and deep learning-guided post-optimization, DRfold2 establishes a distinct direction for advancing ab initio RNA structure prediction.},
  archiveprefix = {bioRxiv},
  chapter = {New Results},
  copyright = {\copyright{} 2025, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/},
  langid = {english},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/XC6C6KUN/Li et al. - 2025 - Ab initio RNA structure prediction with composite language model and denoised end-to-end learning.pdf}
}

@article{linBridgingArtificialIntelligence2025,
  title = {Bridging Artificial Intelligence and Biological Sciences: A Comprehensive Review of Large Language Models in Bioinformatics},
  shorttitle = {Bridging Artificial Intelligence and Biological Sciences},
  author = {Lin, Anqi and Ye, Junpu and Qi, Chang and Zhu, Lingxuan and Mou, Weiming and Gan, Wenyi and Zeng, Dongqiang and Tang, Bufu and Xiao, Mingjia and Chu, Guangdi and Peng, Shengkun and Wong, Hank Z H and Zhang, Lin and Zhang, Hengguo and Deng, Xinpei and Li, Kailai and Zhang, Jian and Jiang, Aimin and Li, Zhengrui and Luo, Peng},
  year = 2025,
  month = jul,
  journal = {Briefings in Bioinformatics},
  volume = {26},
  number = {4},
  pages = {bbaf357},
  issn = {1477-4054},
  doi = {10.1093/bib/bbaf357},
  urldate = {2025-12-26},
  abstract = {Large language models (LLMs), representing a breakthrough advancement in artificial intelligence, have demonstrated substantial application value and development potential in bioinformatics research, particularly showing significant progress in the processing and analysis of complex biological data. This comprehensive review systematically examines the development and applications of LLMs in bioinformatics, with particular emphasis on their advancements in protein and nucleic acid structure prediction, omics analysis, drug design and screening, and biomedical literature mining. This work highlights the distinctive capabilities of LLMs in end-to-end learning and knowledge transfer paradigms. Additionally, this paper thoroughly discusses the major challenges confronting LLMs in current applications, including key issues such as model interpretability and data bias. Furthermore, this review comprehensively explores the potential of LLMs in cross-modal learning and interdisciplinary development. In conclusion, this paper aims to systematically summarize the current research status of LLMs in bioinformatics, objectively evaluate their advantages and limitations, and provide insights and recommendations for future research directions, thereby positioning LLMs as essential tools in bioinformatics research and fostering innovative developments in the biomedical field.},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/2LDBJ9JE/Lin et al. - 2025 - Bridging artificial intelligence and biological sciences a comprehensive review of large language m.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/W2K2JF73/bbaf357.html}
}

@article{liuAnalysisSecondaryStructural2016,
  title = {Analysis of Secondary Structural Elements~in Human {{microRNA}} Hairpin Precursors},
  author = {Liu, Biao and {Childs-Disney}, Jessica L. and Znosko, Brent M. and Wang, Dan and Fallahi, Mohammad and Gallo, Steven M. and Disney, Matthew D.},
  year = 2016,
  month = mar,
  journal = {BMC Bioinformatics},
  volume = {17},
  number = {1},
  pages = {112},
  issn = {1471-2105},
  doi = {10.1186/s12859-016-0960-6},
  urldate = {2026-01-04},
  abstract = {MicroRNAs (miRNAs) regulate gene expression by targeting complementary mRNAs for destruction or translational repression. Aberrant expression of miRNAs has been associated with various diseases including cancer, thus making them interesting therapeutic targets. The composite of secondary structural elements that comprise miRNAs could aid the design of small molecules that modulate their function.},
  langid = {english},
  keywords = {Hairpin Loop,Human RNAs,Internal Loop,Processing Site,Secondary Structural Element},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/HAU95L5S/Liu et al. - 2016 - Analysis of secondary structural elements¬†in human microRNA hairpin precursors.pdf}
}

@article{lorenzViennaRNAPackage202011,
  title = {{{ViennaRNA Package}} 2.0},
  author = {Lorenz, Ronny and Bernhart, Stephan H. and {H{\"o}ner zu Siederdissen}, Christian and Tafer, Hakim and Flamm, Christoph and Stadler, Peter F. and Hofacker, Ivo L.},
  year = 2011,
  month = nov,
  journal = {Algorithms for Molecular Biology},
  volume = {6},
  number = {1},
  pages = {26},
  issn = {1748-7188},
  doi = {10.1186/1748-7188-6-26},
  urldate = {2025-12-26},
  abstract = {Secondary structure forms an important intermediate level of description of nucleic acids that encapsulates the dominating part of the folding energy, is often well conserved in evolution, and is routinely used as a basis to explain experimental findings. Based on carefully measured thermodynamic parameters, exact dynamic programming algorithms can be used to compute ground states, base pairing probabilities, as well as thermodynamic properties.},
  langid = {english},
  keywords = {Consensus Structure,Folding Algorithm,Matthews Correlation Coefficient,Minimum Free Energy,Partition Function},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/FZQN5YAC/Lorenz et al. - 2011 - ViennaRNA Package 2.0.pdf}
}

@article{loveModeratedEstimationFold2014,
  title = {Moderated Estimation of Fold Change and Dispersion for {{RNA-seq}} Data with {{DESeq2}}},
  author = {Love, Michael I. and Huber, Wolfgang and Anders, Simon},
  year = 2014,
  month = dec,
  journal = {Genome Biology},
  volume = {15},
  number = {12},
  pages = {550},
  issn = {1474-760X},
  doi = {10.1186/s13059-014-0550-8},
  urldate = {2025-12-11},
  abstract = {In comparative high-throughput sequencing assays, a fundamental task is the analysis of count data, such as read counts per gene in RNA-seq, for evidence of systematic changes across experimental conditions. Small replicate numbers, discreteness, large dynamic range and the presence of outliers require a suitable statistical approach. We present DESeq2, a method for differential analysis of count data, using shrinkage estimation for dispersions and fold changes to improve stability and interpretability of estimates. This enables a more quantitative analysis focused on the strength rather than the mere presence of differential expression. The DESeq2 package is available at http://www.bioconductor.org/packages/release/bioc/html/DESeq2.html.},
  langid = {english},
  keywords = {DESeq2 Package,Differential Expression Analysis,Negative Binomial Generalize Linear Model,Observe Fisher Information,Read Count},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/9535KYRX/Love et al. - 2014 - Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.pdf}
}

@article{luMolecularCharacteristicsMicrosatellite2023,
  title = {Molecular Characteristics of Microsatellite Stable Early-Onset Colorectal Cancer as Predictors of Prognosis and Immunotherapeutic Response},
  author = {Lu, Can and Zhang, Xiaopeng and Schardey, Josefine and Wirth, Ulrich and Heinrich, Kathrin and Massiminio, Luca and Cavestro, Giulia Martina and Neumann, Jens and Bazhin, Alexandr V. and Werner, Jens and K{\"u}hn, Florian},
  year = 2023,
  month = jul,
  journal = {npj Precision Oncology},
  volume = {7},
  number = {1},
  pages = {63},
  publisher = {Nature Publishing Group},
  issn = {2397-768X},
  doi = {10.1038/s41698-023-00414-8},
  urldate = {2026-01-03},
  abstract = {The incidence of early-onset colorectal cancer (EO-CRC, in patients younger than 50) is increasing worldwide. The specific gene signatures in EO-CRC patients are largely unknown. Since EO-CRC with microsatellite instability is frequently associated with Lynch syndrome, we aimed to comprehensively characterize the tumor microenvironment (TME) and gene expression profiles of EO-CRC with microsatellite stable (MSS-EO-CRC). Here, we demonstrated that MSS-EO-CRC has a similar pattern of tumor-infiltrating immune cells, immunotherapeutic responses, consensus molecular subtypes, and prognosis as late-onset CRC with MSS (MSS-LO-CRC). 133 differential expressed genes were identified as unique gene signatures of MSS-EO-CRC. Moreover, we established a risk score, which was positively associated with PD-L1 expression and could reflect both the level of tumor-infiltrating immune cells and the prognosis of MSS-EO-CRC patients. Application of this score on the anti-PD-L1 treatment cohort demonstrated that the low-risk score group has significant therapeutic advantages and clinical benefits. In addition, candidate driver genes were identified in the different-sidedness of MSS-EO-CRC patients. Altogether, MSS-EO-CRC exhibits distinct molecular profiles that differ from MSS-LO-CRC even though they have a similar TME characterization and survival pattern. Our risk score appears to be robust enough to predict prognosis and immunotherapeutic response and therefore could help to optimize the treatment of MSS-EO-CRC.},
  copyright = {2023 The Author(s)},
  langid = {english},
  keywords = {Cancer genomics,Colorectal cancer},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/K8YJN429/Lu et al. - 2023 - Molecular characteristics of microsatellite stable early-onset colorectal cancer as predictors of pr.pdf}
}

@article{mallaMesothelinExpressionCorrelates2024,
  title = {Mesothelin Expression Correlates with Elevated Inhibitory Immune Activity in Patients with Colorectal Cancer},
  author = {Malla, Midhun and Deshmukh, Sachin Kumar and Wu, Sharon and Samec, Timothy and Olevian, Dane C. and El Naili, Reima and {El-Rayes}, Bassel and Xiu, Joanne and Farrell, Alex and Lenz, Heinz-Josef and Lou, Emil and Goel, Sanjay and Spetzler, David and Goldberg, Richard M. and Hazlehurst, Lori},
  year = 2024,
  month = oct,
  journal = {Cancer Gene Therapy},
  volume = {31},
  number = {10},
  pages = {1547--1558},
  publisher = {Nature Publishing Group},
  issn = {1476-5500},
  doi = {10.1038/s41417-024-00816-1},
  urldate = {2026-01-03},
  abstract = {The expression of the protein Mesothelin (MSLN) is highly variable in several malignancies, including colorectal cancer (CRC), and high levels are associated with aggressive clinicopathological features and worse patient survival. Colorectal cancer is both a common and deadly cancer; being the third most common in incidence and second most common cause of cancer-related death. While systemic therapy remains the primary therapeutic option for most patients with stage IV (metastatic; m) CRC, their disease eventually becomes treatment refractory, and 85\% succumb within 5 years. Microsatellite-stable (MSS) CRC tumors, which constitute more than 90\% of patients with mCRC, are generally refractory to immunotherapeutic interventions. In our current work, we characterize MSLN levels in CRC, specifically correlating expression with clinical outcomes in relevant CRC subtypes, and explore how MSLN expression impacts the status of immune activation and suppression in the peritumoral microenvironment. Higher MSLN expression is prevalent in CMS1 and CMS4 CRC subtypes and correlates with higher gene mutation rates across the patient cohorts. Further, MSLN-high patients exhibit increased M1/M2 macrophage infiltration, PD-L1 staining, immune-inhibitory gene expression, enrichment in inflammatory, TGF-{$\beta$}, IL6/JAK/STAT3, IL2/STAT5 signaling pathways, and mutation in KRAS and FBXW7. Together, these results suggest that MSLN protein is a potential target for antigen-specific therapy and supports investigation into its tumorigenic effects to identify possible therapeutic interventions for patients with high MSLN expressing MSS CRC.},
  copyright = {2024 The Author(s)},
  langid = {english},
  keywords = {Cancer microenvironment,Colorectal cancer},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/RFQ6YGFZ/Malla et al. - 2024 - Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorecta.pdf}
}

@article{mantovaniIL1IL1Regulatory2018,
  title = {{{IL-1}} and {{IL-1}} Regulatory Pathways in Cancer Progression and Therapy},
  author = {Mantovani, Alberto and Barajon, Isabella and Garlanda, Cecilia},
  year = 2018,
  journal = {Immunological Reviews},
  volume = {281},
  number = {1},
  pages = {57--61},
  issn = {1600-065X},
  doi = {10.1111/imr.12614},
  urldate = {2026-01-03},
  abstract = {Inflammation is an important component of the tumor microenvironment. IL-1 is an inflammatory cytokine which plays a key role in carcinogenesis and tumor progression. IL-1 is subject to regulation by components of the IL-1 and IL-1 receptor (ILR) families. Negative regulators include a decoy receptor (IL-1R2), receptor antagonists (IL-1Ra), IL-1R8, and anti-inflammatory IL-37. IL-1 acts at different levels in tumor initiation and progression, including driving chronic non-resolving inflammation, tumor angiogenesis, activation of the IL-17 pathway, induction of myeloid-derived suppressor cells (MDSC) and macrophage recruitment, invasion and metastasis. Based on initial clinical results, the translation potential of IL-1 targeting deserves extensive analysis.},
  copyright = {\copyright{} 2017 John Wiley \& Sons A/S. Published by John Wiley \& Sons Ltd},
  langid = {english},
  keywords = {inflammation,inflammation-associated cancer,interleukin-1,therapy},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/JXZFL25U/Mantovani et al. - 2018 - IL-1 and IL-1 regulatory pathways in cancer progression and therapy.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/MJRC5N3U/imr.html}
}

@article{marques-coelhoDifferentialTranscriptUsage2021,
  title = {Differential Transcript Usage Unravels Gene Expression Alterations in {{Alzheimer}}'s Disease Human Brains},
  author = {{Marques-Coelho}, Diego and Iohan, Lukas da Cruz Carvalho and {Melo de Farias}, Ana Raquel and Flaig, Amandine and Lambert, Jean-Charles and Costa, Marcos Romualdo},
  year = 2021,
  month = jan,
  journal = {npj Aging and Mechanisms of Disease},
  volume = {7},
  number = {1},
  pages = {2},
  publisher = {Nature Publishing Group},
  issn = {2056-3973},
  doi = {10.1038/s41514-020-00052-5},
  urldate = {2025-12-11},
  abstract = {Alzheimer's disease (AD) is the leading cause of dementia in aging individuals. Yet, the pathophysiological processes involved in AD onset and progression are still poorly understood. Among numerous strategies, a comprehensive overview of gene expression alterations in the diseased brain could contribute for a better understanding of the AD pathology. In this work, we probed the differential expression of genes in different brain regions of healthy and AD adult subjects using data from three large transcriptomic studies: Mayo Clinic, Mount Sinai Brain Bank (MSBB), and ROSMAP. Using a combination of differential expression of gene and isoform switch analyses, we provide a detailed landscape of gene expression alterations in the temporal and frontal lobes, harboring brain areas affected at early and late stages of the AD pathology, respectively. Next, we took advantage of an indirect approach to assign the complex gene expression changes revealed in bulk RNAseq to individual cell types/subtypes of the adult brain. This strategy allowed us to identify previously overlooked gene expression changes in the brain of AD patients. Among these alterations, we show isoform switches in the AD causal gene amyloid-beta precursor protein (APP) and the risk gene bridging integrator 1 (BIN1), which could have important functional consequences in neuronal cells. Altogether, our work proposes a novel integrative strategy to analyze RNAseq data in AD and other neurodegenerative diseases based on both gene/transcript expression and regional/cell-type specificities.},
  copyright = {2021 The Author(s)},
  langid = {english},
  keywords = {Alzheimer's disease,Transcription},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/BHI58NP9/Marques-Coelho et al. - 2021 - Differential transcript usage unravels gene expression alterations in Alzheimer‚Äôs disease human brai.pdf}
}

@article{martinez-montielMicrobialNaturalMetabolites2016,
  title = {Microbial and {{Natural Metabolites That Inhibit Splicing}}: {{A Powerful Alternative}} for {{Cancer Treatment}}},
  shorttitle = {Microbial and {{Natural Metabolites That Inhibit Splicing}}},
  author = {{Mart{\'i}nez-Montiel}, Nancy and {Rosas-Murrieta}, Nora Hilda and {Mart{\'i}nez-Montiel}, M{\'o}nica and {Gaspariano-Cholula}, Mayra Patricia and {Mart{\'i}nez-Contreras}, Rebeca D.},
  year = 2016,
  journal = {BioMed Research International},
  volume = {2016},
  number = {1},
  pages = {3681094},
  issn = {2314-6141},
  doi = {10.1155/2016/3681094},
  urldate = {2025-12-26},
  abstract = {In eukaryotes, genes are frequently interrupted with noncoding sequences named introns. Alternative splicing is a nuclear mechanism by which these introns are removed and flanking coding regions named exons are joined together to generate a message that will be translated in the cytoplasm. This mechanism is catalyzed by a complex machinery known as the spliceosome, which is conformed by more than 300 proteins and ribonucleoproteins that activate and regulate the precision of gene expression when assembled. It has been proposed that several genetic diseases are related to defects in the splicing process, including cancer. For this reason, natural products that show the ability to regulate splicing have attracted enormous attention due to its potential use for cancer treatment. Some microbial metabolites have shown the ability to inhibit gene splicing and the molecular mechanism responsible for this inhibition is being studied for future applications. Here, we summarize the main types of natural products that have been characterized as splicing inhibitors, the recent advances regarding molecular and cellular effects related to these molecules, and the applications reported so far in cancer therapeutics.},
  copyright = {Copyright \copyright{} 2016 Nancy Mart\'inez-Montiel et al.},
  langid = {english},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/6FDT7A7W/Mart√≠nez-Montiel et al. - 2016 - Microbial and Natural Metabolites That Inhibit Splicing A Powerful Alternative for Cancer Treatment.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/LRS8RBTG/3681094.html}
}

@article{marxIdentificationDifferentiallyExpressed2024,
  title = {Identification of Differentially Expressed Genes and Splicing Events in Early-Onset Colorectal Cancer},
  author = {Marx, Olivia M. and Mankarious, Marc M. and Koltun, Walter A. and Yochum, Gregory S.},
  year = 2024,
  month = apr,
  journal = {Frontiers in Oncology},
  volume = {14},
  publisher = {Frontiers},
  issn = {2234-943X},
  doi = {10.3389/fonc.2024.1365762},
  urldate = {2025-09-22},
  abstract = {The incidence of colorectal cancer (CRC) has been steadily increasing in younger individuals over the past several decades for reasons that are incompletely defined. Identifying differences in gene expression profiles, or transcriptomes, in early-onset colorectal cancer (EOCRC,  50 years old) patients is one approach to understanding molecular and genetic features that distinguish EOCRC.We performed RNA-sequencing (RNA-seq) to characterize the transcriptomes of patientmatched tumors and adjacent, uninvolved (normal) colonic segments from EOCRC (n=21) and LOCRC (n=22) patients. The EOCRC and LOCRC cohorts were matched for demographic and clinical characteristics. We used The Cancer Genome Atlas Colon Adenocarcinoma (TCGA-COAD) database for validation. We used a series of computational and bioinformatic tools to identify EOCRC-specific differentially expressed genes, molecular pathways, predicted cell populations, differential gene splicing events, and predicted neoantigens.We identified an eight-gene signature in EOCRC comprised of ALDOB, FBXL16, IL1RN, MSLN, RAC3, SLC38A11, WBSCR27 and WNT11, from which we developed a score predictive of overall CRC patient survival. On the entire set of genes identified in normal tissues and tumors, cell type deconvolution analysis predicted a differential abundance of immune and non-immune populations in EOCRC versus LOCRC. Gene set enrichment analysis identified increased expression of splicing machinery in EOCRC. We further found differences in alternative splicing (AS) events, including one within the long non-coding RNA, HOTAIRM1. Additional analysis of AS found seven events specific to EOCRC that encode potential neoantigens.Conclusions: Our transcriptome analyses identified genetic and molecular features specific to EOCRC which may inform future screening, development of prognostic indicators, and novel drug targets.},
  langid = {english},
  keywords = {colorectal cancer,Early-onset,late-onset,Splicing,Transcriptome},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/9PDREYI2/SP_identification_eocrc_locrc.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/L9UNBSD3/Marx et al. - 2024 - Identification of differentially expressed genes and splicing events in early-onset colorectal cance.pdf}
}

@article{marxMolecularGeneticsEarlyonset2023,
  title = {Molecular Genetics of Early-Onset Colorectal Cancer},
  author = {Marx, Olivia and Mankarious, Marc and Yochum, Gregory},
  year = 2023,
  month = mar,
  journal = {World Journal of Biological Chemistry},
  volume = {14},
  number = {2},
  pages = {13--27},
  publisher = {Baishideng Publishing Group Inc.},
  doi = {10.4331/wjbc.v14.i2.13},
  urldate = {2025-12-26},
  abstract = {Molecular genetics of early-onset colorectal cancer},
  langid = {english}
}

@article{mathewsHowBenchmarkRNA2019,
  title = {How to Benchmark {{RNA}} Secondary Structure Prediction Accuracy},
  author = {Mathews, David H.},
  year = 2019,
  month = jun,
  journal = {Methods},
  series = {Experimental and {{Computational Techniques}} for {{Studying Structural Dynamics}} and {{Function}} of {{RNA}}},
  volume = {162--163},
  pages = {60--67},
  issn = {1046-2023},
  doi = {10.1016/j.ymeth.2019.04.003},
  urldate = {2025-10-21},
  abstract = {RNA secondary structure prediction is widely used. As new methods are developed, these are often benchmarked for accuracy against existing methods. This review discusses good practices for performing these benchmarks, including the choice of benchmarking structures, metrics to quantify accuracy, the importance of allowing flexibility for pairs in the accepted structure, and the importance of statistical testing for significance.},
  keywords = {Comparative sequence analysis,RNA folding},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/JG9LKJ5L/Mathews - 2019 - How to benchmark RNA secondary structure prediction accuracy.pdf}
}

@article{meleIdentificationTPM2CNN12022,
  title = {Identification of {{TPM2}} and {{CNN1}} as {{Novel Prognostic Markers}} in {{Functionally Characterized Human Colon Cancer-Associated Stromal Cells}}},
  author = {Mele, Valentina and Basso, Camilla and Governa, Valeria and Glaus Garzon, Jesus F. and Muraro, Manuele G. and D{\"a}ster, Silvio and Nebiker, Christian A. and Mechera, Robert and Bolli, Martin and Schmidt, Alexander and Geiger, Roger and Spagnoli, Giulio C. and Christoforidis, Dimitri and Majno, Pietro E. and Borsig, Lubor and Iezzi, Giandomenica},
  year = 2022,
  month = jan,
  journal = {Cancers},
  volume = {14},
  number = {8},
  pages = {2024},
  publisher = {Multidisciplinary Digital Publishing Institute},
  issn = {2072-6694},
  doi = {10.3390/cancers14082024},
  urldate = {2026-01-03},
  abstract = {Stromal infiltration is associated with poor prognosis in human colon cancers. However, the high heterogeneity of human tumor-associated stromal cells (TASCs) hampers a clear identification of specific markers of prognostic relevance. To address these issues, we established short-term cultures of TASCs and matched healthy mucosa-associated stromal cells (MASCs) from human primary colon cancers and, upon characterization of their phenotypic and functional profiles in vitro and in vivo, we identified differentially expressed markers by proteomic analysis and evaluated their prognostic significance. TASCs were characterized by higher proliferation and differentiation potential, and enhanced expression of mesenchymal stem cell markers, as compared to MASCs. TASC triggered epithelial--mesenchymal transition (EMT) in tumor cells in vitro and promoted their metastatic spread in vivo, as assessed in an orthotopic mouse model. Proteomic analysis of matched TASCs and MASCs identified a panel of markers preferentially expressed in TASCs. The expression of genes encoding two of them, calponin 1 (CNN1) and tropomyosin beta chain isoform 2 (TPM2), was significantly associated with poor outcome in independent databases and outperformed the prognostic significance of currently proposed TASC markers. The newly identified markers may improve prognostication of primary colon cancers and identification of patients at risk.},
  copyright = {http://creativecommons.org/licenses/by/3.0/},
  langid = {english},
  keywords = {CNN1,colon cancer,prognostic markers,proteomics,TPM2,tumor-associated stromal cells},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/683NGVRK/Mele et al. - 2022 - Identification of TPM2 and CNN1 as Novel Prognostic Markers in Functionally Characterized Human Colo.pdf}
}

@article{merinoBenchmarkingWorkflowsDetecting2019,
  title = {A Benchmarking of Workflows for Detecting Differential Splicing and Differential Expression at Isoform Level in Human {{RNA-seq}} Studies},
  author = {Merino, Gabriela A and Conesa, Ana and Fern{\'a}ndez, Elmer A},
  year = 2019,
  month = mar,
  journal = {Briefings in Bioinformatics},
  volume = {20},
  number = {2},
  pages = {471--481},
  issn = {1477-4054},
  doi = {10.1093/bib/bbx122},
  urldate = {2026-01-03},
  abstract = {Over the last few years, RNA-seq has been used to study alterations in alternative splicing related to several diseases. Bioinformatics workflows used to perform these studies can be divided into two groups, those finding changes in the absolute isoform expression and those studying differential splicing. Many computational methods for transcriptomics analysis have been developed, evaluated and compared; however, there are not enough reports of systematic and objective assessment of processing pipelines as a whole. Moreover, comparative studies have been performed considering separately the changes in absolute or relative isoform expression levels. Consequently, no consensus exists about the best practices and appropriate workflows to analyse alternative and differential splicing. To assist the adequate pipeline choice, we present here a benchmarking of nine commonly used workflows to detect differential isoform expression and splicing. We evaluated the workflows performance over different experimental scenarios where changes in absolute and relative isoform expression occurred simultaneously. In addition, the effect of the number of isoforms per gene, and the magnitude of the expression change over pipeline performances were also evaluated. Our results suggest that workflow performance is influenced by the number of replicates per condition and the conditions heterogeneity. In general, workflows based on DESeq2, DEXSeq, Limma and NOISeq performed well over a wide range of transcriptomics experiments. In particular, we suggest the use of workflows based on Limma when high precision is required, and DESeq2 and DEXseq pipelines to prioritize sensitivity. When several replicates per condition are available, NOISeq and Limma pipelines are indicated.},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/TDYVHRJK/Merino et al. - 2019 - A benchmarking of workflows for detecting differential splicing and differential expression at isofo.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/G7BKWKUA/bbx122.html}
}

@article{muznyComprehensiveMolecularCharacterization2012,
  title = {Comprehensive Molecular Characterization of Human Colon and Rectal Cancer},
  author = {Muzny, Donna M. and Bainbridge, Matthew N. and Chang, Kyle and Dinh, Huyen H. and Drummond, Jennifer A. and Fowler, Gerald and Kovar, Christie L. and Lewis, Lora R. and Morgan, Margaret B. and Newsham, Irene F. and Reid, Jeffrey G. and Santibanez, Jireh and Shinbrot, Eve and Trevino, Lisa R. and Wu, Yuan-Qing and Wang, Min and Gunaratne, Preethi and Donehower, Lawrence A. and Creighton, Chad J. and Wheeler, David A. and Gibbs, Richard A. and Lawrence, Michael S. and Voet, Douglas and Jing, Rui and Cibulskis, Kristian and Sivachenko, Andrey and Stojanov, Petar and McKenna, Aaron and Lander, Eric S. and Gabriel, Stacey and Getz, Gad and Ding, Li and Fulton, Robert S. and Koboldt, Daniel C. and Wylie, Todd and Walker, Jason and Dooling, David J. and Fulton, Lucinda and Delehaunty, Kim D. and Fronick, Catrina C. and Demeter, Ryan and Mardis, Elaine R. and Wilson, Richard K. and Chu, Andy and Chun, Hye-Jung E. and Mungall, Andrew J. and Pleasance, Erin and Gordon Robertson, A. and Stoll, Dominik and Balasundaram, Miruna and Birol, Inanc and Butterfield, Yaron S. N. and Chuah, Eric and Coope, Robin J. N. and Dhalla, Noreen and Guin, Ranabir and Hirst, Carrie and Hirst, Martin and Holt, Robert A. and Lee, Darlene and Li, Haiyan I. and Mayo, Michael and Moore, Richard A. and Schein, Jacqueline E. and Slobodan, Jared R. and Tam, Angela and Thiessen, Nina and Varhol, Richard and Zeng, Thomas and Zhao, Yongjun and Jones, Steven J. M. and Marra, Marco A. and Bass, Adam J. and Ramos, Alex H. and Saksena, Gordon and Cherniack, Andrew D. and Schumacher, Stephen E. and Tabak, Barbara and Carter, Scott L. and Pho, Nam H. and Nguyen, Huy and Onofrio, Robert C. and Crenshaw, Andrew and Ardlie, Kristin and Beroukhim, Rameen and Winckler, Wendy and Getz, Gad and Meyerson, Matthew and Protopopov, Alexei and Zhang, Juinhua and Hadjipanayis, Angela and Lee, Eunjung and Xi, Ruibin and Yang, Lixing and Ren, Xiaojia and Zhang, Hailei and Sathiamoorthy, Narayanan and Shukla, Sachet and Chen, Peng-Chieh and Haseley, Psalm and Xiao, Yonghong and Lee, Semin and Seidman, Jonathan and Chin, Lynda and Park, Peter J. and Kucherlapati, Raju and Todd Auman, J. and Hoadley, Katherine A. and Du, Ying and Wilkerson, Matthew D. and Shi, Yan and Liquori, Christina and Meng, Shaowu and Li, Ling and Turman, Yidi J. and Topal, Michael D. and Tan, Donghui and Waring, Scot and Buda, Elizabeth and Walsh, Jesse and Jones, Corbin D. and Mieczkowski, Piotr A. and Singh, Darshan and Wu, Junyuan and Gulabani, Anisha and Dolina, Peter and Bodenheimer, Tom and Hoyle, Alan P. and Simons, Janae V. and Soloway, Matthew and Mose, Lisle E. and Jefferys, Stuart R. and Balu, Saianand and O'Connor, Brian D. and Prins, Jan F. and Chiang, Derek Y. and Neil Hayes, D. and Perou, Charles M. and Hinoue, Toshinori and Weisenberger, Daniel J. and Maglinte, Dennis T. and Pan, Fei and Berman, Benjamin P. and Van Den Berg, David J. and Shen, Hui and Triche Jr, Timothy and Baylin, Stephen B. and Laird, Peter W. and Getz, Gad and Noble, Michael and Voet, Doug and Saksena, Gordon and Gehlenborg, Nils and DiCara, Daniel and Zhang, Juinhua and Zhang, Hailei and Wu, Chang-Jiun and Yingchun Liu, Spring and Shukla, Sachet and Lawrence, Michael S. and Zhou, Lihua and Sivachenko, Andrey and Lin, Pei and Stojanov, Petar and Jing, Rui and Park, Richard W. and Nazaire, Marc-Danie and Robinson, Jim and Thorvaldsdottir, Helga and Mesirov, Jill and Park, Peter J. and Chin, Lynda and Thorsson, Vesteinn and Reynolds, Sheila M. and Bernard, Brady and Kreisberg, Richard and Lin, Jake and Iype, Lisa and Bressler, Ryan and Erkkil{\"a}, Timo and Gundapuneni, Madhumati and Liu, Yuexin and Norberg, Adam and Robinson, Tom and Yang, Da and Zhang, Wei and Shmulevich, Ilya and {de Ronde}, Jorma J. and Schultz, Nikolaus and Cerami, Ethan and Ciriello, Giovanni and Goldberg, Arthur P. and Gross, Benjamin and Jacobsen, Anders and Gao, Jianjiong and Kaczkowski, Bogumil and Sinha, Rileen and Arman Aksoy, B. and Antipin, Yevgeniy and Reva, Boris and Shen, Ronglai and Taylor, Barry S. and Chan, Timothy A. and Ladanyi, Marc and Sander, Chris and Akbani, Rehan and Zhang, Nianxiang and Broom, Bradley M. and Casasent, Tod and Unruh, Anna and Wakefield, Chris and Hamilton, Stanley R. and Craig Cason, R. and Baggerly, Keith A. and Weinstein, John N. and Haussler, David and Benz, Christopher C. and Stuart, Joshua M. and Benz, Stephen C. and Zachary Sanborn, J. and Vaske, Charles J. and Zhu, Jingchun and Szeto, Christopher and Scott, Gary K. and Yau, Christina and Ng, Sam and Goldstein, Ted and Ellrott, Kyle and Collisson, Eric and Cozen, Aaron E. and Zerbino, Daniel and Wilks, Christopher and Craft, Brian and Spellman, Paul and Penny, Robert and Shelton, Troy and Hatfield, Martha and Morris, Scott and Yena, Peggy and Shelton, Candace and Sherman, Mark and Paulauskis, Joseph and {Gastier-Foster}, Julie M. and Bowen, Jay and Ramirez, Nilsa C. and Black, Aaron and Pyatt, Robert and Wise, Lisa and White, Peter and Bertagnolli, Monica and Brown, Jen and Chan, Timothy A. and Chu, Gerald C. and Czerwinski, Christine and Denstman, Fred and Dhir, Rajiv and D{\"o}rner, Arnulf and Fuchs, Charles S. and Guillem, Jose G. and Iacocca, Mary and Juhl, Hartmut and Kaufman, Andrew and Kohl III, Bernard and Van Le, Xuan and Mariano, Maria C. and Medina, Elizabeth N. and Meyers, Michael and Nash, Garrett M. and Paty, Phillip B. and Petrelli, Nicholas and Rabeno, Brenda and Richards, William G. and Solit, David and Swanson, Pat and Temple, Larissa and Tepper, Joel E. and Thorp, Richard and Vakiani, Efsevia and Weiser, Martin R. and Willis, Joseph E. and Witkin, Gary and Zeng, Zhaoshi and Zinner, Michael J. and {The Cancer Genome Atlas Network} and {Genome Sequencing Center Baylor College of Medicine} and {Genome Sequencing Center Broad Institute} and {Genome Sequencing Center Washington University in St Louis} and {Genome Characterization Center BC Cancer Agency} and {Genome-Characterization Center Broad Institute} and {Genome-Characterization Center Brigham and Women's Hospital and Harvard Medical School} and {Genome-Characterization Center University of North Carolina}, Chapel Hill and {Genome-Characterization Centers University of Southern California and Johns Hopkins University} and {Genome Data Analysis Center Broad Institute} and {Genome Data Analysis Center Institute for Systems Biology} and {Genome Data Analysis Center Memorial Sloan-Kettering Cancer Center} and {Genome Data Analysis Center University of Texas MD Anderson Cancer Center} and Genome Data Analysis Centers, Santa Cruz {and} the Buck Institute, University of California and {Biospecimen Core Resource International Genomics Consortium} and {Nationwide Children's Hospital Biospecimen Core Resource} and {Tissue source sites and disease working group}},
  year = 2012,
  month = jul,
  journal = {Nature},
  volume = {487},
  number = {7407},
  pages = {330--337},
  publisher = {Nature Publishing Group},
  issn = {1476-4687},
  doi = {10.1038/nature11252},
  urldate = {2025-09-22},
  abstract = {To characterize somatic alterations in colorectal carcinoma, we conducted a genome-scale analysis of 276 samples, analysing exome sequence, DNA copy number, promoter methylation and messenger RNA and microRNA expression. A subset of these samples (97) underwent low-depth-of-coverage whole-genome sequencing. In total, 16\% of colorectal carcinomas were found to be hypermutated: three-quarters of these had the expected high microsatellite instability, usually with hypermethylation and MLH1 silencing, and one-quarter had somatic mismatch-repair gene and polymerase {$\varepsilon$} (POLE) mutations. Excluding the hypermutated cancers, colon and rectum cancers were found to have considerably similar patterns of genomic alteration. Twenty-four genes were significantly mutated, and in addition to the expected APC, TP53, SMAD4, PIK3CA and KRAS mutations, we found frequent mutations in ARID1A, SOX9 and FAM123B. Recurrent copy-number alterations include potentially drug-targetable amplifications of ERBB2 and newly discovered amplification of IGF2. Recurrent chromosomal translocations include the fusion of NAV2 and WNT pathway member TCF7L1. Integrative analyses suggest new markers for aggressive colorectal carcinoma and an important role for MYC-directed transcriptional activation and repression.},
  copyright = {2012 The Author(s)},
  langid = {english},
  keywords = {Chromosome abnormality,Colorectal cancer,DNA sequencing,Genomics},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/W2IUXI8D/Muzny et al. - 2012 - Comprehensive molecular characterization of human colon and rectal cancer.pdf}
}

@article{nunesPrognosticGenomeTranscriptome2024,
  title = {Prognostic Genome and Transcriptome Signatures in Colorectal Cancers},
  author = {Nunes, Lu{\'i}s and Li, Fuqiang and Wu, Meizhen and Luo, Tian and Hammarstr{\"o}m, Klara and Torell, Emma and Ljuslinder, Ingrid and Mezheyeuski, Artur and Edqvist, Per-Henrik and {L{\"o}fgren-Burstr{\"o}m}, Anna and Zingmark, Carl and Edin, Sofia and Larsson, Chatarina and Mathot, Lucy and Osterman, Erik and Osterlund, Emerik and Ljungstr{\"o}m, Viktor and Neves, In{\^e}s and Yacoub, Nicole and Gudnad{\'o}ttir, Unnur and Birgisson, Helgi and Enblad, Malin and Ponten, Fredrik and Palmqvist, Richard and Xu, Xun and Uhl{\'e}n, Mathias and Wu, Kui and Glimelius, Bengt and Lin, Cong and Sj{\"o}blom, Tobias},
  year = 2024,
  month = sep,
  journal = {Nature},
  volume = {633},
  number = {8028},
  pages = {137--146},
  publisher = {Nature Publishing Group},
  issn = {1476-4687},
  doi = {10.1038/s41586-024-07769-3},
  urldate = {2025-10-08},
  abstract = {Colorectal cancer is caused by a sequence of somatic genomic alterations affecting driver genes in core cancer pathways1. Here, to understand the functional and prognostic impact of cancer-causing somatic mutations, we analysed the whole genomes and transcriptomes of 1,063 primary colorectal cancers in a population-based cohort with long-term follow-up. From the 96 mutated driver genes, 9 were not previously implicated in colorectal cancer and 24~had not been linked to any cancer. Two distinct patterns of pathway co-mutations were observed, timing analyses identified nine early and three late driver gene mutations, and several signatures of colorectal-cancer-specific mutational processes were identified. Mutations in WNT, EGFR and TGF{$\beta$} pathway genes, the mitochondrial CYB gene and 3 regulatory elements along with 21 copy-number variations and the COSMIC SBS44 signature correlated with survival. Gene expression classification yielded five prognostic subtypes with distinct molecular features, in part explained by underlying genomic alterations. Microsatellite-instable tumours divided into two classes with different levels of hypoxia and infiltration of immune and stromal cells. To our knowledge, this study constitutes the largest integrated genome and transcriptome analysis of colorectal cancer, and interlinks mutations, gene expression and patient outcomes. The identification of prognostic mutations and expression subtypes can guide future efforts to individualize colorectal cancer therapy.},
  copyright = {2024 The Author(s)},
  langid = {english},
  keywords = {Cancer genomics,DNA sequencing,Gene expression,Prognostic markers,Tumour biomarkers},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/JZQLRBQZ/Nunes et al. - 2024 - Prognostic genome and transcriptome signatures in colorectal cancers.pdf}
}

@article{patroSalmonProvidesFast2017,
  title = {Salmon Provides Fast and Bias-Aware Quantification of Transcript Expression},
  author = {Patro, Rob and Duggal, Geet and Love, Michael I. and Irizarry, Rafael A. and Kingsford, Carl},
  year = 2017,
  month = apr,
  journal = {Nature Methods},
  volume = {14},
  number = {4},
  pages = {417--419},
  publisher = {Nature Publishing Group},
  issn = {1548-7105},
  doi = {10.1038/nmeth.4197},
  urldate = {2025-12-15},
  abstract = {Salmon is a computational tool that uses sample-specific models and a dual-phase inference procedure to correct biases in RNA-seq data and rapidly quantify transcript abundances.},
  copyright = {2017 Springer Nature America, Inc.},
  langid = {english},
  keywords = {Software,Statistical methods,Transcriptomics},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/24NQD6KS/Patro et al. - 2017 - Salmon provides fast and bias-aware quantification of transcript expression.pdf}
}

@article{penicRiNALMoGeneralpurposeRNA2025,
  title = {{{RiNALMo}}: General-Purpose {{RNA}} Language Models Can Generalize Well on Structure Prediction Tasks},
  shorttitle = {{{RiNALMo}}},
  author = {Peni{\'c}, Rafael Josip and Vla{\v s}i{\'c}, Tin and Huber, Roland G. and Wan, Yue and {\v S}iki{\'c}, Mile},
  year = 2025,
  month = jul,
  journal = {Nature Communications},
  volume = {16},
  number = {1},
  pages = {5671},
  publisher = {Nature Publishing Group},
  issn = {2041-1723},
  doi = {10.1038/s41467-025-60872-5},
  urldate = {2025-09-08},
  abstract = {While RNA has recently been recognized as an interesting small-molecule drug target, many challenges remain to be addressed before we take full advantage of it. This emphasizes the necessity to improve our understanding of its structures and functions. Over the years, sequencing technologies have produced an enormous amount of unlabeled RNA data, which hides a huge potential. Motivated by the successes of protein language models, we introduce RiboNucleic Acid Language Model (RiNALMo) to unveil the hidden code of RNA. RiNALMo is the largest RNA language model to date, with 650M parameters pre-trained on 36M non-coding RNA sequences from several databases. It can extract hidden knowledge and capture the underlying structure information implicitly embedded within the RNA sequences. RiNALMo achieves state-of-the-art results on several downstream tasks. Notably, we show that its generalization capabilities overcome the inability of other deep learning methods for secondary structure prediction to generalize on unseen RNA families.},
  copyright = {2025 The Author(s)},
  langid = {english},
  keywords = {Computational models,Machine learning},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/CWATUYKJ/Peniƒá et al. - 2025 - RiNALMo general-purpose RNA language models can generalize well on structure prediction tasks.pdf}
}

@article{reuterRNAstructureSoftwareRNA2010,
  title = {{{RNAstructure}}: Software for {{RNA}} Secondary Structure Prediction and Analysis},
  shorttitle = {{{RNAstructure}}},
  author = {Reuter, Jessica S. and Mathews, David H.},
  year = 2010,
  month = mar,
  journal = {BMC Bioinformatics},
  volume = {11},
  number = {1},
  pages = {129},
  issn = {1471-2105},
  doi = {10.1186/1471-2105-11-129},
  urldate = {2025-10-13},
  abstract = {To understand an RNA sequence's mechanism of action, the structure must be known. Furthermore, target RNA structure is an important consideration in the design of small interfering RNAs and antisense DNA oligonucleotides. RNA secondary structure prediction, using thermodynamics, can be used to develop hypotheses about the structure of an RNA sequence.},
  keywords = {Base Pair Probability,Class Library,Neighbor Parameter,Secondary Structure Prediction,Structure Prediction},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/5XW4C7R3/Reuter and Mathews - 2010 - RNAstructure software for RNA secondary structure prediction and analysis.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/FHI4G8GE/1471-2105-11-129.html}
}

@article{rivasStatisticalTestConserved2017,
  title = {A Statistical Test for Conserved {{RNA}} Structure Shows Lack of Evidence for Structure in {{lncRNAs}}},
  author = {Rivas, Elena and Clements, Jody and Eddy, Sean R.},
  year = 2017,
  month = jan,
  journal = {Nature Methods},
  volume = {14},
  number = {1},
  pages = {45--48},
  publisher = {Nature Publishing Group},
  issn = {1548-7105},
  doi = {10.1038/nmeth.4066},
  urldate = {2025-12-26},
  abstract = {A new method, R-scape, tests whether observed sequence covariation supports a conserved secondary structure in RNA. The program finds no evidence for previously proposed conserved secondary structures in several lncRNAs.},
  copyright = {2016 Springer Nature America, Inc.},
  langid = {english},
  keywords = {Computational models,Evolution,Long non-coding RNAs,Statistical methods}
}

@book{RNAStructureFunction2023,
  title = {{{RNA Structure}} and {{Function}}},
  year = 2023,
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/KI33XYNN/2023 - RNA Structure and Function.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/WC5YYSMZ/RNA Versus Protein, How Structure Influences Targeting, a New Challenge for Drug Discovery.pdf}
}

@article{satoRecentTrendsRNA2023a,
  title = {Recent Trends in {{RNA}} Informatics: A Review of Machine Learning and Deep Learning for {{RNA}} Secondary Structure Prediction and {{RNA}} Drug Discovery},
  shorttitle = {Recent Trends in {{RNA}} Informatics},
  author = {Sato, Kengo and Hamada, Michiaki},
  year = 2023,
  month = jul,
  journal = {Briefings in Bioinformatics},
  volume = {24},
  number = {4},
  pages = {bbad186},
  issn = {1477-4054},
  doi = {10.1093/bib/bbad186},
  urldate = {2025-12-26},
  abstract = {Computational analysis of RNA sequences constitutes a crucial step in the field of RNA biology. As in other domains of the life sciences, the incorporation of artificial intelligence and machine learning techniques into RNA sequence analysis has gained significant traction in recent years. Historically, thermodynamics-based methods were widely employed for the prediction of RNA secondary structures; however, machine learning-based approaches have demonstrated remarkable advancements in recent years, enabling more accurate predictions. Consequently, the precision of sequence analysis pertaining to RNA secondary structures, such as RNA--protein interactions, has also been enhanced, making a substantial contribution to the field of RNA biology. Additionally, artificial intelligence and machine learning are also introducing technical innovations in the analysis of RNA--small molecule interactions for RNA-targeted drug discovery and in the design of RNA aptamers, where RNA serves as its own ligand. This review will highlight recent trends in the prediction of RNA secondary structure, RNA aptamers and RNA drug discovery using machine learning, deep learning and related technologies, and will also discuss potential future avenues in the field of RNA informatics.},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/7BEC2P7Y/Sato and Hamada - 2023 - Recent trends in RNA informatics a review of machine learning and deep learning for RNA secondary s.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/Z9GP5ZBE/bbad186.html}
}

@article{vaziri-moghadamIntegratingMachineLearning2024,
  title = {Integrating Machine Learning and Bioinformatics Approaches for Identifying Novel Diagnostic Gene Biomarkers in Colorectal Cancer},
  author = {{Vaziri-Moghadam}, Ayoub and {Foroughmand-Araabi}, Mohammad-Hadi},
  year = 2024,
  month = oct,
  journal = {Scientific Reports},
  volume = {14},
  number = {1},
  pages = {24786},
  publisher = {Nature Publishing Group},
  issn = {2045-2322},
  doi = {10.1038/s41598-024-75438-6},
  urldate = {2025-09-30},
  abstract = {This study aimed to identify diagnostic gene biomarkers for colorectal cancer (CRC) by analyzing differentially expressed genes (DEGs) in tumor and adjacent normal samples across five colon cancer gene-expression profiles (GSE10950, GSE25070, GSE41328, GSE74602, GSE142279) from the Gene Expression Omnibus (GEO) database. Intersecting identified DEGs with the module with the highest correlation to gene expression patterns of tumor samples in the gene co-expression network analysis revealed 283 overlapped genes. Centrality measures were calculated for these genes in the reconstructed STRING protein--protein interaction network. Applying LASSO logistic regression, eleven genes were ultimately recognized as candidate diagnostic genes. Among these genes, the area under the receiver operating characteristic curve (AUROC) values for nine genes (CDC25B, CDK4, IQGAP3, MMP1, MMP7, SLC7A5, TEAD4, TRIB3, and UHRF1) surpassed the threshold of 0.92 in both the training and validation sets. We evaluated the diagnostic performance of these genes with four machine learning algorithms: random forest (RF), support vector machines (SVM), artificial neural network (ANN), and gradient boosting machine (GBM). In the testing dataset (GSE21815 and GSE106582), the AUROC scores were greater than 0.95 for all of the machine learning algorithms, indicating the high diagnostic performance of the nine genes. Besides, these nine genes are also significantly correlated to twelve immune cells, namely Mast cells activated, Macrophages M0, M1, and M2, Neutrophils, T cells CD4 memory activated, T cells follicular helper, T cells CD8, T cells CD4 memory resting, B cells memory, Plasma cells, and Mast cells resting (P\,{$<$}\,0.05). These results strongly suggest that all of the nine genes have the potential to serve as reliable diagnostic biomarkers for CRC.},
  copyright = {2024 The Author(s)},
  langid = {english},
  keywords = {Colorectal cancer (CRC),Humanities and Social Sciences,multidisciplinary,Science},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/58F44Y3Y/Vaziri-Moghadam and Foroughmand-Araabi - 2024 - Integrating machine learning and bioinformatics approaches for identifying novel diagnostic gene bio.pdf}
}

@article{velagapudiSequencebasedDesignBioactive2014,
  title = {Sequence-Based Design of Bioactive Small Molecules That Target Precursor {{microRNAs}}},
  author = {Velagapudi, Sai Pradeep and Gallo, Steven M. and Disney, Matthew D.},
  year = 2014,
  month = apr,
  journal = {Nature Chemical Biology},
  volume = {10},
  number = {4},
  pages = {291--297},
  publisher = {Nature Publishing Group},
  issn = {1552-4469},
  doi = {10.1038/nchembio.1452},
  urldate = {2026-01-04},
  abstract = {Oligonucleotide-based RNA targeting is facilitated by base pairing rules, but identifying small molecules that uniquely bind a specific RNA sequence has been challenging. Inforna, an RNA sequence--based lead optimization strategy, was developed and applied to identify small molecules that inhibit pre-microRNA processing.},
  copyright = {2014 Springer Nature America, Inc.},
  langid = {english},
  keywords = {Bioinformatics,Cheminformatics,Non-coding RNAs,Small molecules}
}

@article{vermaniExpressionPatternAldh12020,
  title = {Expression {{Pattern}} of {{Aldh1}}, {{E-Cadherin}}, {{Vimentin}} and {{Twist}} in {{Early}} and {{Late Onset Sporadic Colorectal Cancer}}},
  author = {Vermani, Litika and Kumar, Rajeev and Kannan, Rengaswamy R and Deka, Monoj K and Talukdar, Anuradha and Kumar, Nachimuthu S},
  year = 2020,
  month = oct,
  journal = {Biomarkers in Medicine},
  volume = {14},
  number = {14},
  pages = {1371--1382},
  publisher = {Taylor \& Francis},
  issn = {1752-0363},
  doi = {10.2217/bmm-2020-0206},
  urldate = {2025-12-26},
  abstract = {Aim: To evaluate the expression pattern of ALDH1 (aldehyde dehydrogenase 1), E-cadherin, Vimentin and Twist in early and late onset sporadic colorectal cancer (CRC) and to study association of their expression with the occurrence of CRC at a young age. Materials \& methods: Immunohistochemistry of ALDH1, E-cadherin, Vimentin and Twist was performed on 103 pretreated CRC biopsy samples. Results: ALDH1 expression was found to have strong correlation with early onset CRC (p {$<$} 0.0001). Conclusion: High ALDH1 expression correlates with the early onset of CRC. ALDH1 over-expression correlates with poor overall survival in colon cancer.},
  pmid = {33064013},
  keywords = {ALDH1,cancer stem cell,E-cadherin,epithelial mesenchymal transition,twist,Vimentin,young colorectal cancer}
}

@article{vicensThoughtsHowThink2022a,
  title = {Thoughts on How to Think (and Talk) about {{RNA}} Structure},
  author = {Vicens, Quentin and Kieft, Jeffrey S.},
  year = 2022,
  month = apr,
  journal = {Proceedings of the National Academy of Sciences},
  volume = {119},
  number = {17},
  pages = {e2112677119},
  publisher = {Proceedings of the National Academy of Sciences},
  doi = {10.1073/pnas.2112677119},
  urldate = {2025-03-16},
  abstract = {Recent events have pushed RNA research into the spotlight. Continued discoveries of RNA with unexpected diverse functions in healthy and diseased cells, such as the role of RNA as both the source and countermeasure to a severe acute respiratory syndrome coronavirus 2 infection, are igniting a new passion for understanding this functionally and structurally versatile molecule. Although RNA structure is key to function, many foundational characteristics of RNA structure are misunderstood, and the default state of RNA is often thought of and depicted as a single floppy strand. The purpose of this perspective is to help adjust mental models, equipping the community to better use the fundamental aspects of RNA structural information in new mechanistic models, enhance experimental design to test these models, and refine data interpretation. We discuss six core observations focused on the inherent nature of RNA structure and how to incorporate these characteristics to better understand RNA structure. We also offer some ideas for future efforts to make validated RNA structural information available and readily used by all researchers.},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/6VUNUIJW/Vicens et Kieft - 2022 - Thoughts on how to think (and talk) about RNA stru.pdf}
}

@article{vitting-seerupIsoformSwitchAnalyzeRAnalysisChanges2019,
  title = {{{IsoformSwitchAnalyzeR}}: Analysis of Changes in Genome-Wide Patterns of Alternative Splicing and Its Functional Consequences},
  shorttitle = {{{IsoformSwitchAnalyzeR}}},
  author = {{Vitting-Seerup}, Kristoffer and Sandelin, Albin},
  year = 2019,
  month = nov,
  journal = {Bioinformatics},
  volume = {35},
  number = {21},
  pages = {4469--4471},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/btz247},
  urldate = {2025-12-23},
  abstract = {Alternative splicing is an important mechanism involved in health and disease. Recent work highlights the importance of investigating genome-wide changes in splicing patterns and the subsequent functional consequences. Current computational methods only support such analysis on a gene-by-gene basis. Therefore, we extended IsoformSwitchAnalyzeR R library to enable analysis of genome-wide changes in specific types of alternative splicing and predicted functional consequences of the resulting isoform switches. As a case study, we analyzed RNA-seq data from The Cancer Genome Atlas and found systematic changes in alternative splicing and the consequences of the associated isoform switches.Windows, Linux and Mac OS: http://bioconductor.org/packages/IsoformSwitchAnalyzeR.Supplementary data are available at Bioinformatics online.},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/2QEE3BZ9/Vitting-Seerup and Sandelin - 2019 - IsoformSwitchAnalyzeR analysis of changes in genome-wide patterns of alternative splicing and its f.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/DJV3TQWL/btz247.html}
}

@article{vogelsteinCancerGenomeLandscapes2013,
  title = {Cancer Genome Landscapes},
  author = {Vogelstein, Bert and Papadopoulos, Nickolas and Velculescu, Victor E. and Zhou, Shibin and Diaz, Luis A. and Kinzler, Kenneth W.},
  year = 2013,
  month = mar,
  journal = {Science (New York, N.Y.)},
  volume = {339},
  number = {6127},
  pages = {1546--1558},
  issn = {1095-9203},
  doi = {10.1126/science.1235122},
  abstract = {Over the past decade, comprehensive sequencing efforts have revealed the genomic landscapes of common forms of human cancer. For most cancer types, this landscape consists of a small number of "mountains" (genes altered in a high percentage of tumors) and a much larger number of "hills" (genes altered infrequently). To date, these studies have revealed \textasciitilde 140 genes that, when altered by intragenic mutations, can promote or "drive" tumorigenesis. A typical tumor contains two to eight of these "driver gene" mutations; the remaining mutations are passengers that confer no selective growth advantage. Driver genes can be classified into 12 signaling pathways that regulate three core cellular processes: cell fate, cell survival, and genome maintenance. A better understanding of these pathways is one of the most pressing needs in basic cancer research. Even now, however, our knowledge of cancer genomes is sufficient to guide the development of more effective approaches for reducing cancer morbidity and mortality.},
  langid = {english},
  pmcid = {PMC3749880},
  pmid = {23539594},
  keywords = {Cell Transformation Neoplastic,Genes Neoplasm,Genetic Heterogeneity,Genome Human,Humans,Mutagenesis,Mutation,Neoplasms,Signal Transduction},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/XZQRF7Y8/Vogelstein et al. - 2013 - Cancer genome landscapes.pdf}
}

@article{wangIL1RNPRRX1Prognostic2022,
  title = {{{IL1RN}} and {{PRRX1}} as a {{Prognostic Biomarker Correlated}} with {{Immune Infiltrates}} in {{Colorectal Cancer}}: {{Evidence}} from {{Bioinformatic Analysis}}},
  shorttitle = {{{IL1RN}} and {{PRRX1}} as a {{Prognostic Biomarker Correlated}} with {{Immune Infiltrates}} in {{Colorectal Cancer}}},
  author = {Wang, Qi and Huang, Xufeng and Zhou, Shujing and Ding, Yuntao and Wang, Huizhi and Jiang, Weiye and Xu, Min},
  year = 2022,
  journal = {International Journal of Genomics},
  volume = {2022},
  number = {1},
  pages = {2723264},
  issn = {2314-4378},
  doi = {10.1155/2022/2723264},
  urldate = {2026-01-03},
  abstract = {The extensive morbidity of colorectal cancer (CRC) and the inferior prognosis of terminal CRC urgently call for reliable prognostic biomarkers. For this, we identified 704 differentially expressed genes (DEGs) by intersecting three datasets, GSE41328, GSE37364, and GSE15960 from Gene Expression Omnibus database, to maximize the accuracy of the results. Preliminary analysis of the DEGs was then performed using online gene analysis datasets, such as DAVID, UCSC Cancer Genome Browser, CBioPortal, STRING, and UCSC Cancer Genome Browser. Cytoscape was utilized to visualize the protein perception interaction network of DEGs, and the bubble map of GO and KEGG enrichment function was demonstrated using the R package. The Molecular Complex Detection (MCODE), Biological Network Gene Oncology (BiNGO) plug-in in Cytoscape, was applied to further screen the DEGs to obtain 15 seed genes, which were IL1RN, GALNT12, ADH6, SCN7A, CXCL1, FGF18, SOX9, ACACB, PRRX1, MZB1, SLC22A3, CNNM4, LY6E, IFITM2, and GDPD3. Among them, IL1RN, ADH6, SCN7A, ACACB, MZB1, and GDPD3 exhibited statistically significant survival differences, whereas limited studies were conducted in CRC. Based on the enrichment results of the ``Gene Ontology``(GO) and ``Kyoto Encyclopedia of Genes and genomes ``(KEGG) as well as documented findings of key genes, we further emphasized the potential of IL1RN and PRRX1 as markers of immune infiltrates in CRC and confirmed our hypothesis by compiling data from the UALCAN, Tumor Immune Estimation Resource, and TISIDB databases for these two genes. The above-mentioned genes might offer a valuable insight into the diagnosis, immunotherapeutic targets, and prognosis of CRC.},
  copyright = {Copyright \copyright{} 2022 Qi Wang et al.},
  langid = {english},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/96ZPGN2V/Wang et al. - 2022 - IL1RN and PRRX1 as a Prognostic Biomarker Correlated with Immune Infiltrates in Colorectal Cancer E.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/PN4H5J2L/2723264.html}
}

@article{washietlFastReliablePrediction2005,
  title = {Fast and Reliable Prediction of Noncoding {{RNAs}}},
  author = {Washietl, Stefan and Hofacker, Ivo L. and Stadler, Peter F.},
  year = 2005,
  month = feb,
  journal = {Proceedings of the National Academy of Sciences},
  volume = {102},
  number = {7},
  pages = {2454--2459},
  publisher = {Proceedings of the National Academy of Sciences},
  doi = {10.1073/pnas.0409169102},
  urldate = {2025-12-26},
  abstract = {We report an efficient method for detecting functional RNAs. The approach, which combines comparative sequence analysis and structure prediction, already has yielded excellent results for a small number of aligned sequences and is suitable for large-scale genomic screens. It consists of two basic components: (i) a measure for RNA secondary structure conservation based on computing a consensus secondary structure, and (ii) a measure for thermodynamic stability, which, in the spirit of a z score, is normalized with respect to both sequence length and base composition but can be calculated without sampling from shuffled sequences. Functional RNA secondary structures can be identified in multiple sequence alignments with high sensitivity and high specificity. We demonstrate that this approach is not only much more accurate than previous methods but also significantly faster. The method is implemented in the program rnaz, which can be downloaded from www.tbi.univie.ac.at/\textasciitilde wash/RNAz. We screened all alignments of length n {$\geq$} 50 in the Comparative Regulatory Genomics database, which compiles conserved noncoding elements in upstream regions of orthologous genes from human, mouse, rat, Fugu, and zebrafish. We recovered all of the known noncoding RNAs and cis-acting elements with high significance and found compelling evidence for many other conserved RNA secondary structures not described so far to our knowledge.},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/AR8DWZTY/Washietl et al. - 2005 - Fast and reliable prediction of noncoding RNAs.pdf}
}

@article{watsonDifferentialExpressionPEG102020,
  title = {Differential {{Expression}} of {{PEG10 Contributes}} to {{Aggressive Disease}} in {{Early Versus Late-Onset Colorectal Cancer}}},
  author = {Watson, Katherine M. and Gardner, Ivy H. and Byrne, Raphael M. and Ruhl, Rebecca R. and Lanciault, Christian P. and Dewey, Elizabeth N. and Anand, Sudarshan and Tsikitis, Vassiliki Liana},
  year = 2020,
  month = dec,
  journal = {Diseases of the Colon \& Rectum},
  volume = {63},
  number = {12},
  pages = {1610},
  issn = {0012-3706},
  doi = {10.1097/DCR.0000000000001774},
  urldate = {2025-12-26},
  abstract = {BACKGROUND:~           Colorectal cancer is a leading cause of cancer-related death. Early onset colorectal cancer (age {$\leq$}45 y) is increasing and associated with advanced disease. Although distinct molecular subtypes of colorectal cancer have been characterized, it is unclear whether age-related molecular differences exist.           OBJECTIVE:~           We sought to identify differences in gene expression between early and late-onset (age {$\geq$}65 y) colorectal cancer.           DESIGN:~           We performed a review of our institution's colorectal cancer registry and identified patients with colorectal cancer with tissue specimens available for analysis. We used the Cancer Genome Atlas to initially identify differences in gene expression between early and late-onset colorectal cancer. In vitro experiments were performed on 2 colorectal cancer cell lines.           SETTINGS:~           The study was conducted at a tertiary medical center.           PATIENTS:~           Patients with early onset (n = 28) or late onset (age {$\geq$}65 y; n = 38) at time of diagnosis were included.           MAIN OUTCOME MEASURES:~           The primary outcome was differential gene expression in patients with early versus late-onset colorectal cancer. The secondary outcome was patient mortality.           RESULTS:~           Seven genes had increased expression in younger patients using The Cancer Genome Atlas. Only PEG10 was sufficiently expressed with quantitative polymerase chain reaction and had increased expression in our early onset group. Multivariable linear regression analysis identified age as a significant independent predictor of increased PEG10 expression. Outcomes data from The Cancer Genome Atlas suggests that PEG10 is associated with poor overall survival. In vitro studies in HCT-116 and HT-29 cell lines showed that PEG10 contributes to cellular proliferation and invasion in colorectal cancer.           LIMITATIONS:~           Tissue samples were from formalin-fixed, paraffin-embedded sections. Many patients did not have mutational status for review.           CONCLUSIONS:~           PEG10 is differentially expressed in early onset colorectal cancer and may functionally contribute to tumor cell proliferation and invasion. An increase in PEG10 expression correlates with decreased overall survival. See Video Abstract at https://links.lww.com/DCR/B343.           LA EXPRESI\'ON DIFERENCIAL DE PEG10 CONTRIBUYE A LA ENFERMEDAD AGRESIVA EN EL C\'ANCER COLORRECTAL DE INICIO TEMPRANO VERSUS INICIO TARD\'IO~           ANTECEDENTES:           El c\'ancer colorrectal es una de las principales causas de muerte relacionada con el c\'ancer. El c\'ancer colorrectal de inicio temprano (edad {$\leq$}45 a\~nos) est\'a en aumento y asociado con enfermedad avanzada. Aunque se han caracterizado distintos subtipos moleculares del c\'ancer colorrectal, no est\'a claro si existen diferencias moleculares relacionadas con la edad.           OBJETIVO:           Se busc\'o identificar diferencias en la expresi\'on g\'enica entre el c\'ancer colorrectal de inicio temprano y tard\'io (edad {$\geq$} 65 a\~nos).           DISE\~NO:           Realizamos una revisi\'on del registro de c\'ancer colorrectal de nuestra instituci\'on e identificamos pacientes con c\'ancer colorrectal con muestras de tejido disponibles para su an\'alisis. Utilizamos el Atlas del Genoma del C\'ancer para identificar inicialmente las diferencias en la expresi\'on g\'enica entre el c\'ancer colorrectal de inicio temprano y de inicio tard\'io. Se realizaron experimentos in vitro en dos l\'ineas celulares de c\'ancer colorrectal.           AJUSTES:           El estudio se realiz\'o en un centro m\'edico de tercer nivel.           PACIENTES:           Se incluyeron pacientes con inicio temprano (n = 28) e inicio tard\'io (edad {$\geq$}65 a\~nos, n = 38) al momento del diagn\'ostico.           PRINCIPALES MEDIDAS DE RESULTADO:           El resultado primario fue la expresi\'on diferencial de genes en pacientes con c\'ancer colorrectal de inicio temprano versus tard\'io. El resultado secundario fue la mortalidad de los pacientes.           RESULTADOS:           Siete genes aumentaron su expresi\'on en pacientes m\'as j\'ovenes usando el Atlas del Genoma del C\'ancer. Solo PEG10 se expres\'o suficientemente con la reacci\'on en cadena de la polimerasa cuantitativa y tuvo una mayor expresi\'on en nuestro grupo de inicio temprano. El an\'alisis de regresi\'on lineal multivariable identific\'o la edad como un predictor independiente significativo del aumento de la expresi\'on de PEG10. Los datos de resultados de el Atlas del Genoma del C\'ancer sugieren que PEG10 est\'a asociado con una pobre supervivencia general. Los estudios in vitro en l\'ineas celulares HCT-116 y HT-29 mostraron que PEG10 contribuye a la proliferaci\'on e invasi\'on celular en el c\'ancer colorrectal.           LIMITACIONES:           Las muestras de tejido fueron de portaobjetos embebidos en parafina fijados con formalina. Muchos pacientes no ten\'ian el estado de mutaci\'on para su revisi\'on.           CONCLUSIONES:           El PEG10 se expresa diferencialmente en el c\'ancer colorrectal de inicio temprano y puede contribuir funcionalmente a la proliferaci\'on e invasi\'on de c\'elulas tumorales. El aumento en la expresi\'on de PEG10 se correlaciona con la disminuci\'on de la supervivencia general. Consulte Video Resumen en https://links.lww.com/DCR/B343.},
  langid = {american},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/D3Q27EGS/differential_expression_of_peg10_contributes_to.9.html}
}

@article{willauerClinicalMolecularCharacterization2019,
  title = {Clinical and Molecular Characterization of Early-Onset Colorectal Cancer},
  author = {Willauer, Alexandra N. and Liu, Yusha and Pereira, Allan A. L. and Lam, Michael and Morris, Jeffrey S. and Raghav, Kanwal P. S. and Morris, Van K. and Menter, David and Broaddus, Russell and {Meric-Bernstam}, Funda and {Hayes-Jordan}, Andrea and Huh, Winston and Overman, Michael J. and Kopetz, Scott and Loree, Jonathan M.},
  year = 2019,
  journal = {Cancer},
  volume = {125},
  number = {12},
  pages = {2002--2010},
  issn = {1097-0142},
  doi = {10.1002/cncr.31994},
  urldate = {2025-12-23},
  abstract = {Background Colorectal cancer (CRC) incidence is increasing in adults younger than 50 years. This study evaluated clinical and molecular features to identify those features unique to early-onset CRC that differentiate these patients from patients 50 years old or older. Methods Baseline characteristics were evaluated according to the CRC onset age with 3 independent cohorts. A fourth cohort was used to describe the impact of age on the consensus molecular subtype (CMS) prevalence. Results This retrospective review of more than 36,000 patients with CRC showed that early-onset patients were more likely to have microsatellite instability (P = .038), synchronous metastatic disease (P = .009), primary tumors in the distal colon or rectum (P {$<$} .0001), and fewer BRAF V600 mutations (P {$<$} .001) in comparison with patients 50 years old or older. Patients aged 18 to 29 years had fewer adenomatous polyposis coli (APC) mutations (odds ratio [OR], 0.56; 95\% confidence interval [CI], 0.35-0.90; P = .015) and an increased prevalence of signet ring histology (OR, 4.89; 95\% CI, 3.23-7.39; P {$<$} .0001) in comparison with other patients younger than 50 years. In patients younger than 40 years, CMS1 was the most common subtype, whereas CMS3 and CMS4 were uncommon (P = .003). CMS2 was relatively stable across age groups. Early-onset patients with inflammatory bowel disease were more likely to have mucinous or signet ring histology (OR, 5.54; 95\% CI, 2.24-13.74; P = .0004) and less likely to have APC mutations (OR, 0.24; 95\% CI, 0.07-0.75; P = .019) in comparison with early-onset patients without predisposing conditions. Conclusions Early-onset CRC is not only distinct from traditional CRC: special consideration should be given to and further investigations should be performed for both very young patients with CRC (18-29 years) and those with predisposing conditions. The etiology of the high rate of CMS1 in patients younger than 40 years deserves further exploration.},
  copyright = {\copyright{} 2019 American Cancer Society},
  langid = {english},
  keywords = {age,colorectal cancer,consensus molecular subtypes,CpG island methylator phenotype (CIMP),early onset,hereditary,inflammatory bowel disease,mutations},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/UPMTJZ8R/Willauer et al. - 2019 - Clinical and molecular characterization of early-onset colorectal cancer.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/6PIVIAGX/cncr.html}
}

@article{wuClusterProfiler40Universal2021,
  title = {{{clusterProfiler}} 4.0: {{A}} Universal Enrichment Tool for Interpreting Omics Data},
  shorttitle = {{{clusterProfiler}} 4.0},
  author = {Wu, Tianzhi and Hu, Erqiang and Xu, Shuangbin and Chen, Meijun and Guo, Pingfan and Dai, Zehan and Feng, Tingze and Zhou, Lang and Tang, Wenli and Zhan, Li and Fu, Xiaocong and Liu, Shanshan and Bo, Xiaochen and Yu, Guangchuang},
  year = 2021,
  month = aug,
  journal = {The Innovation},
  volume = {2},
  number = {3},
  pages = {100141},
  issn = {2666-6758},
  doi = {10.1016/j.xinn.2021.100141},
  urldate = {2025-12-23},
  abstract = {Functional enrichment analysis is pivotal for interpreting high-throughput omics data in life science. It is crucial for this type of tool to use the latest annotation databases for as many organisms as possible. To meet these requirements, we present here an updated version of our popular Bioconductor package, clusterProfiler 4.0. This package has been enhanced considerably compared with its original version published 9 years ago. The new version provides a universal interface for functional enrichment analysis in thousands of organisms based on internally supported ontologies and pathways as well as annotation data provided by users or derived from online databases. It also extends the dplyr and ggplot2 packages to offer tidy interfaces for data operation and visualization. Other new features include gene set enrichment analysis and comparison of enrichment results from multiple gene lists. We anticipate that clusterProfiler 4.0 will be applied to a wide range of scenarios across diverse organisms.},
  keywords = {biological knowledge mining,clusterProfiler,enrichment analysis,functional analysis,visualization},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/QL6GN39K/Wu et al. - 2021 - clusterProfiler 4.0 A universal enrichment tool for interpreting omics data.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/K26MYSVX/S2666675821000667.html}
}

@article{xuGermlineProfilingMolecular2020,
  title = {Germline {{Profiling}} and {{Molecular Characterization}} of {{Early Onset Metastatic Colorectal Cancer}}},
  author = {Xu, Ting and Zhang, Yinjie and Zhang, Jing and Qi, Changsong and Liu, Dan and Wang, Zhenghang and Li, Yanyan and Ji, Congcong and Li, Jian and Lin, Xuan and Hou, Ting and Liu, Hao and Zhang, Lu and {Han-Zhang}, Han and Shen, Lin and Wang, Xicheng},
  year = 2020,
  month = oct,
  journal = {Frontiers in Oncology},
  volume = {10},
  publisher = {Frontiers},
  issn = {2234-943X},
  doi = {10.3389/fonc.2020.568911},
  urldate = {2025-12-23},
  abstract = {BackgroundEarly onset colorectal cancer (EOCRC) is a heterogeneous colorectal cancer subtype with obvious hereditary tendencies and increasing incidence. We sought to determine the susceptibility genes and molecular characteristics of EOCRC.Methods330 EO metastatic CRC (mCRC) ({$\leq$}55 years) and 110 average-onset (AO) mCRC patients (\&gt;55 years) were enrolled. Capture-based targeted sequencing was performed on tumor tissue and paired white blood cells using a sequencing panel of 520 genes. The association between molecular alterations and overall survival (OS) was analyzed.ResultsOf the 330 EO mCRC patients, 31 carried pathogenic or likely pathogenic germline mutations, with 16 of them diagnosed with lynch syndrome. Fifteen patients had germline mutations in non-mismatch repair genes, including 4 in MUTHY, 3 in RAD50, 1 in TP53, and 8 in other genes. Twenty-nine genes were recurrently mutated in EO mCRC, including TP53, APC, KRAS, SMAD4, and BRCA2. The majority of genomic alterations were comparable between EO and AO mCRC. EO mCRC were more likely to have a high tumor mutation burden (p \&lt; 0.05). RNF43, RBM10, TSC, and BRAF V600E mutations were more commonly observed in EO mCRC, while APC, ASXL1, DNMT3B, and MET genes were more commonly altered in AO patients. At the pathway level, the WNT pathway was the only differentially mutated pathway between EO and AO mCRC (p \&lt; 0.0001). The wild-type WNT pathway (p = 0.0017) and mutated TGF-{$\beta$} pathway (p = 0.023) were associated with unfavorable OS in EO mCRC.ConclusionsApproximately 1 in 10 EO mCRC were associated with hereditary tumors. The spectrum of somatic alterations was largely comparable between EO and AO mCRC with several notable differences.},
  langid = {english},
  keywords = {Early onset colorectal cancer,genomic alternation,next generation seqencing,prognosis,susceptibility gene}
}

@article{yanOrganoidCulturesEarlyonset2020,
  title = {Organoid Cultures of Early-Onset Colorectal Cancers Reveal Distinct and Rare Genetic Profiles},
  author = {Yan, Helen H. N. and Siu, Hoi Cheong and Ho, Siu Lun and Yue, Sarah S. K. and Gao, Yang and Tsui, Wai Yin and Chan, Dessy and Chan, April S. and Wong, Jason W. H. and Man, Alice H. Y. and Lee, Bernard C. H. and Chan, Annie S. Y. and Chan, Anthony K. W. and Hui, Ho Sang and Cheung, Arthur K. L. and Law, Wai Lun and Lo, Oswens S. H. and Yuen, Siu Tsan and Clevers, Hans and Leung, Suet Yi},
  year = 2020,
  month = dec,
  publisher = {BMJ Publishing Group},
  doi = {10.1136/gutjnl-2019-320019},
  urldate = {2025-12-26},
  abstract = {Objective Sporadic early-onset colorectal cancer (EOCRC) has bad prognosis, yet is poorly represented by cell line models. We examine the key mutational and transcriptomic alterations in an organoid biobank enriched in EOCRCs. Design We established paired cancer (n=32) and normal organoids (n=18) from 20 patients enriched in microsatellite-stable EOCRC. Exome and transcriptome analysis was performed. Results We observed a striking diversity of molecular phenotypes, including PTPRK-RSPO3 fusions. Transcriptionally, RSPO fusion organoids resembled normal colon organoids and were distinct from APC mutant organoids, with high BMP2 and low PTK7 expression. Single cell transcriptome analysis confirmed the similarity between RSPO fusion organoids and normal organoids, with a propensity for maturation on Wnt withdrawal, whereas the APC mutant organoids were locked in progenitor stages. CRISPR/Cas9 engineered mutation of APC in normal human colon organoids led to upregulation of PTK7 protein and suppression of BMP2 , but less so with an engineered RNF43 mutation. The frequent co-occurrence of RSPO fusions with SMAD4 or BMPR1A mutation was confirmed in TCGA database searches. RNF43 mutation was found in organoid from a leukaemia survivor with a novel mutational signature; and organoids with POLE proofreading mutation displayed ultramutation. The cancer organoid genomes were stable over long culture periods, while normal human colon organoids tended to be subject to clonal dominance over time. Conclusions These organoid models enriched in EOCRCs with linked genomic data fill a gap in existing CRC models and reveal distinct genetic profiles and novel pathway cooperativity.},
  chapter = {Colon},
  copyright = {\copyright{} Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.},
  langid = {english}
}

@article{zablockiComprehensiveBenchmarkingLarge2025,
  title = {Comprehensive Benchmarking of Large Language Models for {{RNA}} Secondary Structure Prediction},
  author = {Zablocki, Luciano I and Bugnon, Leandro A and Gerard, Matias and Di Persia, Leandro and Stegmayer, Georgina and Milone, Diego H},
  year = 2025,
  month = mar,
  journal = {Briefings in Bioinformatics},
  volume = {26},
  number = {2},
  pages = {bbaf137},
  issn = {1477-4054},
  doi = {10.1093/bib/bbaf137},
  urldate = {2025-10-19},
  abstract = {In recent years, inspired by the success of large language models (LLMs) for DNA and proteins, several LLMs for RNA have also been developed. These models take massive RNA datasets as inputs and learn, in a self-supervised way, how to represent each RNA base with a semantically rich numerical vector. This is done under the hypothesis that obtaining high-quality RNA representations can enhance data-costly downstream tasks, such as the fundamental RNA secondary structure prediction problem. However, existing RNA-LLM have not been evaluated for this task in a unified experimental setup. Since they are pretrained models, assessment of their generalization capabilities on new structures is a crucial aspect. Nonetheless, this has been just partially addressed in literature. In this work we present a comprehensive experimental and comparative analysis of pretrained RNA-LLM that have been recently proposed. We evaluate the use of these representations for the secondary structure prediction task with a common deep learning architecture. The RNA-LLM were assessed with increasing generalization difficulty on benchmark datasets. Results showed that two LLMs clearly outperform the other models, and revealed significant challenges for generalization in low-homology scenarios. Moreover, in this study we provide curated benchmark datasets of increasing complexity and a unified experimental setup for this scientific endeavor. Source code and curated benchmark datasets with increasing complexity are available in the repository: https://github.com/sinc-lab/rna-llm-folding/.},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/H2YRZI3I/rnallm_supp_bbaf137.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/KMHQUK2F/Zablocki et al. - 2025 - Comprehensive benchmarking of large language models for RNA secondary structure prediction.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/XYCQBTTE/bbaf137.html}
}

@article{zhangAdvancesOpportunitiesRNA2022,
  title = {Advances and Opportunities in {{RNA}} Structure Experimental Determination and Computational Modeling},
  author = {Zhang, Jinsong and Fei, Yuhan and Sun, Lei and Zhang, Qiangfeng Cliff},
  year = 2022,
  month = oct,
  journal = {Nature Methods},
  volume = {19},
  number = {10},
  pages = {1193--1207},
  publisher = {Nature Publishing Group},
  issn = {1548-7105},
  doi = {10.1038/s41592-022-01623-y},
  urldate = {2025-10-21},
  abstract = {Beyond transferring genetic information, RNAs are molecules with diverse functions that include catalyzing biochemical reactions and regulating gene expression. Most of these activities depend on RNAs' specific structures. Therefore, accurately determining RNA structure is integral to advancing our understanding of RNA functions. Here, we summarize the state-of-the-art experimental and computational technologies developed to evaluate RNA secondary and tertiary structures. We also highlight how the rapid increase of experimental data facilitates the integrative modeling approaches for better resolving RNA structures. Finally, we provide our thoughts on the latest advances and challenges in RNA structure determination methods, as well as on future directions for both experimental approaches and artificial intelligence-based computational tools to model RNA structure. Ultimately, we hope the technological advances will deepen our understanding of RNA biology and facilitate RNA structure-based biomedical research such as designing specific RNA structures for therapeutics and deploying RNA-targeting small-molecule drugs.},
  copyright = {2022 Springer Nature America, Inc.},
  langid = {english},
  keywords = {Machine learning,RNA sequencing},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/HTYAECX9/Zhang et al. - 2022 - Advances and opportunities in RNA structure experimental determination and computational modeling.pdf}
}

@article{zhangIsoformLevelExpression2013,
  title = {Isoform Level Expression Profiles Provide Better Cancer Signatures than Gene Level Expression Profiles},
  author = {Zhang, ZhongFa and Pal, Sharmistha and Bi, Yingtao and Tchou, Julia and Davuluri, Ramana V.},
  year = 2013,
  month = apr,
  journal = {Genome Medicine},
  volume = {5},
  number = {4},
  pages = {33},
  issn = {1756-994X},
  doi = {10.1186/gm437},
  urldate = {2026-01-03},
  abstract = {The majority of mammalian genes generate multiple transcript variants and protein isoforms through alternative transcription and/or alternative splicing, and the dynamic changes at the transcript/isoform level between non-oncogenic and cancer cells remain largely unexplored. We hypothesized that isoform level expression profiles would be better than gene level expression profiles at discriminating between non-oncogenic and cancer cellsgene level.},
  langid = {english},
  keywords = {Cluster Purity,Human Mammary Epithelial Cell,Ingenuity Pathway Analysis,Silhouette Width,Transcript Variant},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/8QHGK5G7/Zhang et al. - 2013 - Isoform level expression profiles provide better cancer signatures than gene level expression profil.pdf}
}

@article{zhengComprehensiveAssessmentDiet2021,
  title = {Comprehensive {{Assessment}} of {{Diet Quality}} and {{Risk}} of {{Precursors}} of~{{Early-Onset Colorectal Cancer}}},
  author = {Zheng, Xiaobin and Hur, Jinhee and Nguyen, Long H and Liu, Jie and Song, Mingyang and Wu, Kana and {Smith-Warner}, Stephanie A and Ogino, Shuji and Willett, Walter C and Chan, Andrew T and Giovannucci, Edward and Cao, Yin},
  year = 2021,
  month = may,
  journal = {JNCI: Journal of the National Cancer Institute},
  volume = {113},
  number = {5},
  pages = {543--552},
  issn = {0027-8874},
  doi = {10.1093/jnci/djaa164},
  urldate = {2026-01-03},
  abstract = {The role of poor diet quality in the rising incidence of colorectal cancer (CRC) diagnosed younger than age 50 years has not been explored. Based on molecular features of early-onset CRC, early-onset adenomas are emerging surrogate endpoints.In a prospective cohort study (Nurses' Health Study II), we evaluated 2 empirical dietary patterns (Western and prudent) and 3 recommendation-based indexes (Dietary Approaches to Stop Hypertension [DASH], Alternative Mediterranean Diet [AMED], and Alternative Healthy Eating Index [AHEI]-2010) with risk of early-onset adenoma overall and by malignant potential (high-risk: {$\geq$}1\,cm, tubulovillous or villous histology, high-grade dysplasia, or {$\geq$}3 adenomas), among 29 474 women with 1 or more lower endoscopy before age 50 years (1991--2011). Multivariable logistic regressions were used to estimate odds ratios (ORs) and 95\% confidence intervals (CIs).We documented 1157 early-onset adenomas with 375 at high risk. Western diet was positively associated, whereas prudent diet, DASH, AMED, and AHEI-2010 were inversely associated with risk of early-onset adenoma. The associations were largely confined to high-risk adenomas (the highest vs lowest quintile: Western, OR = 1.67, 95\% CI = 1.18 to 2.37; prudent, OR = 0.69, 95\% CI = 0.48 to 0.98; DASH, OR = 0.65, 95\% CI = 0.45 to 0.93; AMED, OR = 0.55, 95\% CI = 0.38 to 0.79; AHEI-2010,\,OR =\,0.71, 95\% CI = 0.51 to 1.01; all Ptrend {$\leq$} .03), driven by those identified in the distal colon and rectum (all Ptrend {$\leq$} .04, except AMED: Ptrend = .14).Poor diet quality was associated with an increased risk of early-onset distal and rectal adenomas of high malignant potential. These findings provide preliminary but strong support to the role of diet in early-onset CRC.},
  file = {/Users/smarquez/Dropbox/Public/zotero/storage/N9YQUUCK/Zheng et al. - 2021 - Comprehensive Assessment of Diet Quality and Risk of Precursors of¬†Early-Onset Colorectal Cancer.pdf;/Users/smarquez/Dropbox/Public/zotero/storage/7LEE7FD4/djaa164.html}
}
